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The secretory pathway is essential for proper cell functioning and starts when mRNAs encoding 
membrane and secretory proteins are targeted to the endoplasmic reticulum (ER). However, little is 
known about the contribution of RNA-binding proteins to the recognition, localization and 
translation of ER-localized mRNAs.  
In this work, we characterized the human RNA-binding protein HDLBP by using a variety of 
biochemical, transcriptomic and proteomic approaches. We identified that HDLBP binds to more 
than 80% of all ER-localized mRNAs by PAR-CLIP, cell fractionation and RNA-sequencing 
experiments. Analysis of the HDLBP binding motif showed that it predominantly binds to a CU-
containing motif and forms high affinity multivalent interactions primarily in the coding sequence 
(CDS) of ER-localized mRNAs. In contrast, we identified that cytosolic HDLBP mRNA targets show 
less HDLBP binding sites randomly distributed between the CDS or 3’ untranslated regions. This 
indicates that ER-localized mRNAs per se differ from cytosol-localized mRNAs in their sequence 
composition with regard to HDLBP binding sites.  
Further PAR-CLIP analysis revealed that HDLBP interacts with RNA components of the signal 
recognition particle (SRP) and the 40S ribosomal subunit. We identified by BioID experiments 
proteins in close proximity to HDLBP and thereby confirmed the association of HDLBP with 
components of the translational apparatus and the SRP. 
Functional studies using CRISPR-Cas9 HDLBP knockout (KO) cell lines in combination with ribosome 
profiling demonstrated that HDLBP promotes the translation of its ER-localized target mRNAs. We 
validated this finding by pSILAC experiments and detected the corresponding decrease in protein 
synthesis of proteins encoded by mRNAs that are bound by HDLBP and ER-localized. Furthermore, 
we determined the effect of HDLBP on secretion and membrane-protein surface expression and 
found that both are impaired in absence of HDLBP.   
Lastly, in vivo experiments with nude mice showed that HDLBP KO resulted in a decrease of lung 
tumor formation highlighting the relevance of HDLBP for tumor progression. Overall, these results 
demonstrate a general function for HDLBP in the translation of ER-localized mRNAs.  
 
  





Der Sekretionsweg ist essenziell für die ordnungsgemäße Funktion von Zellen und beginnt, wenn 
mRNAs, die für Membran- und Sekretionsproteine codieren, an das endoplasmatische Retikulum 
(ER) gebracht werden. Allerdings ist wenig darüber bekannt, inwiefern RNA-bindende Proteine zur 
Erkennung, Lokalisierung und Translation von ER lokalisierten mRNAs beitragen.  
In dieser Arbeit haben wir das humane RNA-bindende Protein HDLBP mithilfe verschiedener 
biochemischer, transkriptomischer und proteomischer Methoden charakterisiert. Wir haben durch 
PAR-CLIP-, Zellfraktionierungs- und RNA-Seqeuenzierexperimente festgestellt, dass HDLBP an mehr 
als 80% aller ER lokalisierten mRNAs bindet. Analysen zu HDLBPs Bindungsmotiv haben gezeigt, 
dass HDLBP vorwiegend an ein CU-haltiges Motiv bindet und hoch affine, multivalente 
Wechselwirkungen mit der codierenden Sequenz (CDS) hauptsächlich von ER lokalisierten mRNAs 
eingeht. Im Gegensatz dazu haben wir festgestellt, dass zytosolische HDLBP gebundene mRNAs 
weniger Bindungsstellen aufweisen und dass diese sowohl in der CDS als auch in 3‘ untranslatierten 
Regionen auftreten. Dies zeigt, dass sich ER lokalisierte mRNAs von Zytosol lokalisierten mRNAs in 
ihrer Sequenzzusammensetzung hinsichtlich der HDLBP Bindungsstellen unterscheiden.  
Weitere Analysen des PAR-CLIP-Experiments ergaben, dass HDLBP mit RNA-Komponenten des 
Signalerkennungspartikels (SRP) und der 40S ribosomalen Untereinheit interagiert. Durch BioID-
Experimente haben wir Proteine in unmittelbarer Nähe zu HDLBP bestimmt und konnten damit die 
Assoziation von HDLBP mit Komponenten des Translationsapparates und des SRPs bestätigen.  
Funktionelle Studien, bei denen wir CRISPR-Cas9 erzeugte HDLBP Knockout (KO) Zelllinien in 
Kombination mit Ribosomen-Profiling verwendet haben, haben gezeigt, dass HDLBP die Translation 
von mRNAs fördert, die an HDLBP gebunden und am ER lokalisiert sind. Dies haben wir durch 
pSILAC-Experimente validiert und die entsprechende Abnahme der Proteinsynthese von Proteinen 
festgestellt, die von mRNAs codiert werden, die an HDLBP gebunden und am ER lokalisiert sind. 
Darüber hinaus haben wir die Wirkung von HDLBP auf die Sekretion und die Oberflächenexpression 
von Membranproteinen untersucht und herausgefunden, dass HDLBPs Abwesenheit beides 
beeinträchtigt.  
Letztlich haben in vivo Experimente mit Nacktmäusen ergeben, dass HDLBP KO eine Abnahme der 
Lungentumorbildung verursacht, was die Relevanz von HDLBP für die Tumorprogression 
hervorhebt. Insgesamt zeigt unsere Arbeit eine generelle Funktion von HDLBP bei der Translation 
von ER lokalisierten mRNAs. 
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INTRODUCTION 
The secretory pathway 
Secretion of certain proteins to the extracellular space is essential for eukaryotic cells and needed for 
multiple purposes like cell homeostasis, hormone release and neurotransmission. Constitutive 
secretion is fundamental for every cell and key factors of the pathway are ubiquitously expressed 
and highly conserved. In addition, there are specialized secretory cells such as pancreatic beta-cells 
secreting insulin. Here, the secretion is regulated and triggered by extracellular stimuli. The 
conventional secretory pathway includes both constitutive and regulated secretion and covers all 
steps from mRNA translation to the secretion of the mature protein (Viotti, 2016). A schematic 
overview is shown in Figure I. Moreover, the secretory pathway includes the biosynthesis of 
membrane proteins which is similar to secretory protein biosynthesis. Only the last step differs 
because membrane proteins are integrated into the plasma membrane, whereas secretory proteins 
are secreted. Each step is regulated and quality control pathways are in place to ensure the correct 
procedure (McCaffrey and Braakman, 2016). Mis-regulation can lead to several disease phenotypes 
like cancer or neurodegenerative diseases (Wang and Kaufman, 2016).  
 
The secretory pathway starts when mRNAs encoding 
a signal sequence or transmembrane domain are co-
translationally targeted to the endoplasmic reticulum 
(ER). During translation the nascent peptides are 
translocated into the ER lumen where they are folded 
and packed into vesicles. These vesicles are 
transported to the Golgi apparatus. After several 
posttranslational modifications the mature proteins 
are encapsulated into secretory granules, leave the 
Golgi apparatus and are transported via the 
cytoskeleton to the plasma membrane. The granules 
fuse with the plasma membrane and the proteins are 
secreted or integrated into the plasma membrane.  
 
Besides the conventional secretory pathway, alternative routes that do not involve the ER-to-Golgi 
transport are described as unconventional protein secretion pathways (Rabouille, 2017).  






 Figure I | Overview of the secretory pathway. 
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The ER 
The ER consist of a flattened membrane enclosed 
sacs or tubes known as cisternae. This membrane 
network can have a surface area that is 25 fold 
greater than the membrane surrounding it. The 
cisternae create a special environment for 
example in regard of calcium concentration which 
is critical for several cellular processes (Shibata et 
al., 2006). The ER was first described in the 1940s 
and one of the early electron microscopy ER 
images taken by the Nobel Prize winner George 
Palade is shown in Figure II (George E. Palade, 
1966). It clearly shows the membrane organization of the ER and in addition the ER-associated 
ribosomes are visible. It was estimated that half of all ribosomes in a cell are in close proximity to the 
ER (Reid and Nicchitta, 2015). According to the dogma, these ribosomes should translate mRNAs 
encoding membrane and secretory proteins. However, it was shown in several studies that some 
mRNAs encoding cytosolic proteins are translated at the ER as well (Jagannathan et al., 2014; 
Mueckler and Pitot, 1982; Reid and Nicchitta, 2012; Voigt et al., 2017). 
This raises the questions: How does a cell decide where an mRNA is translated and which factors 
influence that decision? How are ER-targeted mRNAs recognized and transported to the ER?  
 
Targeting mRNAs to the ER 
Major contributions to answer these questions came from the lab of Günter Blobel where the signal 
recognition particle (SRP) was discovered. The SRP is important for recognition and targeting of 
specific mRNAs co-translationally to the ER (see chapter “The signal recognition particle”). Blobel´s 
work was fundamental for our understanding of the secretory pathway and awarded with the Nobel 
Prize in 1999. Nevertheless, it has been shown that neither loss nor mutation of the SRP compromises 
the localization of numerous mRNAs to the ER (Costa et al., 2018; Lakkaraju et al., 2007; Mutka and 
Walter, 2001; Pyhtila et al., 2008) suggesting that multiple mechanisms for ER localization exist. 
Discovering these pathways is an outstanding challenge in the field and in recent years some progress 
has been made. In 2007, the TRC40/GET pathway was described explaining how tail-anchored 
proteins, which contain a single C-terminal transmembrane domain, are post-translationally targeted 
to the ER (Schuldiner et al., 2008; Stefanovic and Hegde, 2007). In addition, the SND (SRP-
iNDependent targeting) proteins were identified in 2016 as an alternative targeting route to the ER 
Figure II | Electron microscopy picture of the rough ER 
taken by Palade. The small black dots are ribosomes. 
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in yeast (Aviram et al., 2016). It was demonstrated that SND proteins are able to compensate loss of 
the SRP and it was suggested that they act as a backup system. The mammalian SND pathway is not 
fully characterized yet and not all human homologues have been identified (Aviram and Schuldiner, 
2017). Overall, this shows that the fundamental question of how mRNAs are targeted to the ER is still 
not fully understood and that future research is needed to discover additional ER-targeting 
pathways. 
 
Regulatory elements influencing ER-targeting  
Besides the efforts to discover ER-targeting pathways, also the role of regulatory elements within 
mRNA sequences have been of high interest. Are there regulatory elements that contribute to ER-
targeting? Blobel and colleagues proposed already in 1971 that proteins encode cis signals that 
determine their destination (Blobel and Sabatini, 1971) and it was shown that mRNAs encoding 
secretory proteins contain a N-terminal sequence encoding hydrophobic signal peptides that 
mediate SRP binding and ER-targeting. However, not all ER-targeted mRNAs contain these sequences 
but are still present at the ER.  
Over the last decades, other regulatory elements were identified. It was observed that mRNAs 
encoding transmembrane proteins have a high uracil content suggesting that uracil-rich mRNAs are 
targeted to the ER. But further investigations showed that this feature is not sufficient to predict ER 
association (Cui and Palazzo, 2014; Prilusky and Bibi, 2009). In addition, regulatory elements 
influencing ER-targeting were described to be either located within the coding sequence (CDS) (Cui 
et al., 2013; Pechmann et al., 2014; Polyansky et al., 2013) or in the 3’ untranslated regions (3’UTRs) 
(Chartron et al., 2016; Loya et al., 2008).  
Recently, a global regulatory element occurring in the CDS but also in untranslated regions was 
identified (Cohen-Zontag et al., 2019). This cis-acting RNA sequence motif in ER-targeted mRNAs was 
termed SECReTE as secretion enhancing cis-regulatory targeting element and is present in humans 
and several eukaryotic organisms. The motif consists of up to 10 nucleotide triplet repeats enriched 
with pyrimidine (C and U) every third base. It is highly abundant in mRNAs encoding secretory 
proteins and it was shown in yeast that mutations within this motif impact ER localization, 
translation and secretion of these proteins. Furthermore, a screening in yeast was carried out to 
identify RNA-binding proteins that interact with SECeTE and several candidates were detected, but 
their role in protein secretion needs to be further determined (Cohen-Zontag et al., 2019).   
Taken together, that suggest that cis-regulatory elements like SECReTE influence ER-targeting and 
downstream processing of membrane and secretory proteins. However, trans-acting factors that 
recognize such elements have not been characterized yet.    
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Translation at the ER 
Targeting mRNAs to the ER is mainly mediated by the SRP (see next chapter) and coupled to 
translation. Therefore, in this section, the translation process will be introduced and the similarities 
and differences between cytosolic and ER translation will be highlighted. The translation of mRNA 
into protein is an extremely conserved, essential and very energy consuming process. It is highly 
regulated to ensure that the correct proteins are made in the proper places within the cell.  
 
Similarities between cytosolic and ER translation 
Translation can be subdivided in 4 main phases: initiation, elongation, termination and ribosome 
recycling (Schuller and Green, 2018) which are in principal identical between the cytosol and the ER. 
First, a complex consisting of eukaryotic initiation factors (eIF1, eIF1A, eIF3, eIF5), the initiator tRNA 
(Met-tRNA) and eIF2-GTP binds to the 40S small ribosomal subunit and forms the pre-initiation 
complex (PIC). PIC recognizes the cap of an mRNA that was preactivated by eIF4F and poly(A)-
binding protein. After removal of secondary mRNA structures by RNA helicases PIC starts to scan the 
5’ untranslated region (5’UTR) for complementarity to the anticodon of the Met-tRNA. This scanning 
is promoted by eIF5. Once a start codon is found the 60S large ribosomal subunit joins PIC, which is 
catalyzed by eIF5B, and the 80S ribosome is complete (Hinnebusch, 2014). In total, it consists of 4 
ribosomal RNAs (rRNAs) (18S, 28S, 5.8S, 5S) and 82 ribosomal proteins.  
Next, elongation begins and GTP hydrolysis together with several eukaryotic elongation factors 
(mainly eEF1A, eEF2) enable the ribosome to move along the mRNA, 3 nucleotides per step. The 
mRNA itself consists of 3-letter codons that give rise to a total of 64 possible codons which encode 
20 amino acids and stop signals. The codons are 
recognized and the appropriate transfer RNAs (tRNAs) 
delivers the corresponding amino acid which results in 
a growing peptide chain and later the final protein. The 
charged tRNA enters the A site (aminoacyl site) of the 
ribosome for GTP dependent peptide-bond formation 
(Figure III). Due to a conformational shift of the 
ribosome the tRNA moves to the P site (peptidyl site) 
and the amino acid is attached to the peptide chain. 
Lastly, the uncharged tRNA is moved to the E site (exit 
site) where it dissociates from the ribosome (Schuller 
and Green, 2018).  
 
Figure III | Simplified scheme of the ribosome
showing the E, P and A site.  
large subunit
small subunit






.  .  . A U G C U U .  .  .
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This elongation process can be paused or stalled for multiple reasons like low levels of cognate 
charged tRNAs. The mRNA sequence itself can form secondary structures like pseudoknots resulting 
in ribosome pausing or the mRNA contains suboptimal codons leading to a supply limit of the 
corresponding tRNAs. Inhibitory conformations of the nascent peptide in the ribosome exit tunnel 
can also cause stalling. Then, either the machinery manages to continue translation or the ribosome 
becomes a target of quality control pathways (Buskirk and Green, 2017).  
Once the ribosome reaches a stop signal the eukaryotic release factor eRF1 binds to the A site and 
with help of additional factors like eRF3 the nascent protein is released. Subsequently, the ribosome 
is recycled into the small and large ribosomal subunit primarily by ABCE1. 
 
Differences between cytosolic and ER translation 
Differences between cytosolic and ER translation remain incompletely explored. However, it was 
proposed that ER-associated translation is more efficient compared to cytosolic translation (Reid and 
Nicchitta, 2012). That is based on ribosome profiling of cell fractionated HEK293 cells that showed 
higher ribosome loading on ER-bound mRNAs compared to cytosolic mRNAs. In line with that, a 
recent single molecule imaging study detected more ribosomes on reporter mRNAs at the ER in 
comparison to the cytosol pointing out that cytosolic versus ER-associated translation are not 
identical and regulated differently (Voigt et al., 2017).  
To understand how cytosolic and ER translation are regulated differently several aspects come into 
question.  
First of all: do the ribosomes themselves differ in their composition? Ribosome heterogeneity was 
already suggested by Palade after he discovered the ribosomes (Palade, 1955) and is since then 
discussed in the field. Evidence is emerging that the ribosomes have distinct compositions in regard 
to the protein components but also regarding rRNA modifications (Genuth and Barna, 2018). A 
cryoelectron tomography study suggested that ER-associated polyribosomes have a specific three-
dimensional arrangement which is different from cytosolic polyribosomes and which could explain 
why ER-associated ribosomes show higher translation efficiency (Pfeffer et al., 2012). 
Secondly, specificity of ribosomes is also achieved by ribosome associated proteins. In a screen using 
mouse embryonic stem cells (mESCs) around 400 proteins were detected to be associated with the 
ribosome (Simsek et al., 2017). PKM2, a metabolic enzyme with RNA-binding ability, was discovered 
to interact with sub-pools of ER-associated ribosomes and to activate the translation of specific ER- 
targeted mRNAs. Nevertheless, no comprehensive differences regarding the composition, assembly 
or the translation states of ER-associated or cytosolic ribosomes have been identified.   
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Thirdly, RNA-binding proteins (RBPs) can contribute to translation regulation at the ER. LIN28A was 
shown to bind RNA and to inhibit translation of ER-targeted mRNAs in mESCs (Cho et al., 2012). 
Interestingly, LIN28A was also identified as a ribosome associated protein in the screen mentioned 
above (Simsek et al., 2017). Therefore, it is not clear if LIN28A achieves its specificity for ER-targeted 
mRNAs by binding to the mRNA and/or to the ribosome. Apart from LIN28A, no other RBPs have 
been described to regulate translation specifically at the ER.  
In summary, only few aspects are already discovered to contribute to ER-specific translation and 




The signal recognition particle (SRP) 
The signal recognition particle´s (SRP) major function is to facilitate co-translational ER-targeting of 
membrane and secretory proteins. It was discovered in the 1980´s and the core of the established 
SRP pathway remains unchanged to the present and will be summarized in this chapter. However, 
recent advances in technology have challenged some aspects of the SRP model and will be pointed 
out as well.  
 
In eukaryotes, the SRP consists out of a ~300 nt long 7SL RNA scaffold and 6 proteins which are 
named according to their molecular weight (SRP9, SRP14, SRP19, SRP54, SRP68, SRP72) (Walter and 
Blobel, 1980). It is highly conserved and the bacteria SRP consists of a 4.5S RNA and only one SRP 
protein (SRP54/Ffh). This simplified SRP version is able to replace the eukaryotic SRP in vitro 
(Bernstein et al., 1993) demonstrating the evolutionary conservation of this pathway. According to 
the SRP pathway (Figure IV), the SRP recognizes and binds to its substrates in the cytosol during 
translation. The translation is stopped and the complex moves to the ER where the nascent protein 
chain is translocated into the ER lumen. The SRP dissociates and translation continues. In order to 
ensure proper function of this cycle there are several check points. Thereby, the specificity of the SRP 
is achieved which is crucial for the correct targeting of intrinsically insoluble SRP substrates.  
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First, the SRP recognizes its substrates in the cytosol by a characteristic signal sequence that emerges 
from the ribosome exit tunnel. Secretory proteins contain a cleavable signal sequence, whereas 
membrane proteins have at least one non-cleavable transmembrane domain which has similar 
features as the signal sequence. The signal sequence is highly divergent regarding its length and 
amino acids composition but usually has a core of 8-12 hydrophobic amino acids, forms a α-helical 
structure and has basic residues at the N-terminus (Zhang and Shan, 2014). It needs to be recognized 
by the SRP before the translation exceeds a length of ~140 amino acids so that the SRP has a time 
window of around 3-5 seconds to recognize its substrate. Strong signal sequences recruit the SRP 
with a high affinity and mutation experiments showed that the binding affinity decreases by ~100 
fold as the signal sequence is weakened (Zhang and Shan, 2014). Nevertheless, the SRP engages with 
strong and weak signal sequences at the ribosome exit tunnel and eliminates their exposure to the 
cytosol. Therefore, the hydrophobic groove of SRP54 accommodates the α-helical structure of the 
signal sequence and the methionine-rich M domain of SRP54 acts as a lid to additionally protect the 
signal peptides (Guna and Hegde, 2018). 
 
Furthermore, SRP binding to the nascent chain complex leads to a translation arrest allowing the 
complex to move to the ER. The translation arrest was discovered by in vitro translation experiments 
using microsomal membranes representing the ER (Walter and Blobel, 1981). Fundamental for these 
experiments was the observation that in vitro translation of mRNAs containing a signal sequence 
results in a mature or immature protein depending on the presence of microsomal membranes. The 
mature protein is made when microsomal membranes are added to the reaction and is ~3 kDa 




















Figure IV | Schematic representation of the SRP pathway.   
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sequence of the mature protein is cleaved by the signal peptidase which is part of microsomal 
membranes. In contrast, the ~3 kDa larger, immature protein still contains the signal sequence and 
is synthesized in absence of microsomal membranes. Making use of this observation an experiment 
was carried out where an mRNA was translated in the presence and absence of SRP and in addition 
microsomal membranes were added to the reaction at different time points. A simplified scheme of 




Strikingly, no protein product was observed in the reaction when the SRP was present but 
microsomal membranes were absent. Only upon addition of microsomal membranes the mRNA was 
translated and the mature protein was detected. In contrast, no translation arrest was observed in 
absence of SRP and microsomal membranes and only the immature protein product was detected. 
That proved that the SRP causes translation arrest which is undone upon addition of microsomal 
membranes. More than 20 years later the structure of the SRP bound to an elongation-arrested 
ribosome was solved and suggests that the Alu domain of the 7SL RNA is responsible for the 
translation arrest because it reaches the ribosomal binding site of elongation factors and thereby 
blocks their binding (Halic et al., 2004). This translation arrest allows the SRP complex to move to 
the ER and only correctly assembled complexes are steady enough to reach the ER. Incorrect 
complexes are up to 50 fold less stable (Zhang and Shan, 2014). 
 
Once the SRP reaches the ER a GTP-dependent interaction with the SRP receptor takes place to 
unload the substrate. Unlike classical GTPases the SRP and SRP receptor are twin GTPases that do 
not need external GTPase activating proteins and instead activate each other by discrete 
conformational changes (Zhang and Shan, 2014). The coordinated progression of the conformational 







Flourograph detecting radiolabeled proteins
+ SRP- SRP



















Figure V | Simplified scheme of in vitro translation experiments that proved that the SRP causes a translation arrest.   
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changes is critical for the subsequent successful translocation of SRP substrates through the 
translocation channels e.g. Sec61 into the ER lumen. After GTP hydrolysis, the SRP dissociates back 
to the cytosol and the cycle starts over.  
 
In summary, the specificity of the SRP is achieved through multiple checkpoints and SRP substrates 
are only correctly targeted to the ER if the SRP binds tightly to the signal sequence, the SRP complex 
is delivered quickly to the ER and GTP hydrolysis of the SRP - SRP receptor complex is well timed. 
 
More recent findings 
Recent technology advances and methods like ribosome profiling broadened our understanding of 
the SRP pathway. The client range of SRP was determined on a global scale by immunopurification 
of SRP and subsequent ribosome profiling to identify ribosome bound mRNA sequences in yeast 
(Chartron et al., 2016) and bacteria (Schibich et al., 2016). As expected, these experiments confirmed 
several points of the SRP hypothesis like high affinity of the SRP for hydrophobic amino acids within 
proteins harboring transmembrane domains. In addition, yeast ribosome profiling confirmed on the 
one hand that the SRP binds the ribosome-nascent-chain complex once the signal sequence is 
exposed. But on the other hand also ribosome-protected fragments upstream of the signal sequence 
were detected for many SRP substrates suggesting that the SRP can engage with the ribosome before 
the signal sequence is synthesized (Chartron et al., 2016). SRP pre-recruitment to the ribosome 
would have the advantage that the signal sequence can be bound faster after it emerges the ribosome 
exit tunnel. Moreover, SRP pre-recruitment provides an explanation how the SRP ensures punctual 
and correct binding to signal sequences. This is especially relevant considering the fact that 
translating ribosomes have a cellular concentration of 40-50 μM which is over 100 fold higher 
compared to the concentration of the SRP (Zhang and Shan, 2014). However, it is unknown how the 
SRP is pre-recruited to some but not other ribosomes and which factors mediate this binding.  
 
These ribosome profiling experiments also started a debate about the relationship between SRP and 
translation. It was proposed that they did not confirm the initial observation from the 1980´s of a 
translation arrest once the SRP is bound to the ribosome-nascent-chain complex (Chartron et al., 
2016; Guna and Hegde, 2018; Schibich et al., 2016). This statement is for example based on bacteria 
SRP selective ribosome profiling analysis. Here, the majority of SRP substrates were aligned 
according to their first SRP binding and the coverage after this binding was evaluated (Schibich et al., 
2016). The authors argued that in theory this first SRP binding should mediate a translation arrest 
which should be detected by a peak in ribosome profiling data. However, this peak was not observed 
suggesting that the SRP is not causing a translation slowdown in bacteria. In line with that also the 
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yeast ribosome profiling results suggest that there is no classical translation arrest and that the 
elongation proceeds after the SRP binds (Chartron et al., 2016). This is based on cell fractionated 
ribosome profiling where first the membrane and soluble fraction were separated by centrifugation 
and subsequently ribosome profiling was carried out on both fractions. A schematic overview of this 
experiment and as well the results for one representative SRP substrate containing 4 transmembrane 
domains (OLE1) are shown in Figure VI.  
 
 
As expected the number of ribosome reads from the soluble fraction diminished after the targeting 
signal emerged from the ribosome exit tunnel. Nevertheless, some ribosome reads from the soluble 
fraction were still detected even after the targeting signal was fully translated suggesting that the 
SRP bound ribosome nascent chain complex remained soluble, elongation proceeded and therefore 
translation was not arrested. In summary, both yeast and bacteria ribosome profiling studies doubt 
the existence of an SRP-mediated translational arrest. However, this is based on the expectation that 
the first SRP substrate binding occurs directly after exposure of the signal sequence and immediately 
causes a translation arrest allowing no further translation in the cytosol. But clearly, the discovery 
that SRP pre-recruitment to ribosome nascent chain complexes exists, challenges this expectation. 
SRP pre-recruitment suggests that the SRP has alternative binding strategies besides the SRP 
hypothesis meaning that the SRP is not only binding its substrates when the first signal sequence is 
exposed but also earlier. Therefore, it can be speculated that SRP binding does not immediately lead 
to a translation arrest, but instead the translation arrest occurs at multiple positions along the mRNA. 
Thereby, it would be difficult to detect a translation arrest in ribosome profiling data because the 






































Figure VI | Simplified scheme of the experimental set up of yeast ribosome profiling and results for the transmembrane 
domain containing protein OLE1. Figure was reprinted with modifications from Chartron et al., 2016. 
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translation arrest are not fully understood and it is not clear at which time point exactly the arrest 
occurs especially considering cases where the SRP is pre-recruited to its substrates. Likewise, it is 
unknown which other factors contribute to translational arrest.  
 
Apart from challenging the SRP hypothesis regarding the translational arrest, the ribosome profiling 
experiments also opened up the question about de novo translation initiation at the ER. According to 
the current believes, the SRP only binds to free cytosolic ribosomes and at the end of an SRP cycle, 
the SRP and the ribosome dissociate back to the cytosol. This was already doubted and discussed in 
several articles (Hsu and Nicchitta, 2018; Jagannathan et al., 2014; Reid and Nicchitta, 2015) because 
it would exclude de novo translation initiation at the ER. The ribosome profiling experiment 
described in Figure VI now shows that ribosome-protected fragments are found in both the 
membrane and soluble fraction before the targeting signal is translated. According to the SRP 
hypothesis, no reads should be detected in the membrane fraction before the targeting signal 
emerged. However, these reads are observed and assuming that this is not due to cross 
contamination of the membrane and soluble fraction that would suggest that translation can be also 
initiated at the ER. 
 
This conclusion is also supported by another study where ER selective ribosome profiling was carried 
out (Jan et al., 2014). To achieve ER specificity a biotin ligase was fused to an ER-resident protein and 
thereby only Avi-tagged ribosomes at the ER surface were biotinylated, purified and sequenced. Here, 
ribosome-protected reads were also observed before the targeting sequence was translated. Authors 
suggested a model wherein the pioneering round of translation facilitates ER-targeting of the 
ribosome-nascent-chain complex and afterwards the mRNA remains ER-associated and following 
ribosome are able to engage with the mRNA before the targeting signal is exposed (Jan et al., 2014).  
 
Taken together, ribosome profiling revealed new insights into SRP function and opened up several 
points for clarification like further investigation of SRP-mediated translation arrest or mechanistic 
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The 15 KH domain-containing RBP HDLBP 
The previous chapters highlighted that the secretory pathway is important for proper cell functioning 
and that, besides the well-established key points of the pathway, several mechanistic details are not 
fully understood. Certainly, there is evidence that additional ER-targeting pathways besides the SRP 
exist. Furthermore, cis-acting regulatory elements within the mRNA sequence have been identified 
to mediate ER-targeting, but no trans-acting factors like RNA-binding proteins are characterized to 
specifically bind these elements. In addition, mechanistic details within the SRP cycle and especially 
concerning the SRP-mediated translational arrest remain to be determined. Moreover, factors 
influencing ER-specific translation are unknown.  
In order to contribute to uncover this lack of knowledge, we chose to study the RNA-binding protein 
HDLBP. Here, we will first introduce HDLBP and its characteristics and subsequently summarize the 
proposed functions of HDLBP and finally emphasize its disease relevance.   
 
Characteristics  
The protein HDLBP was first described in 1987 and it was found to bind to one of the major 
lipoproteins HDL (High-density lipoprotein) (Graham and Oram, 1987). Therefore, it was named 
high-density lipoprotein binding protein (HDLBP) which is the official gene name. HDLBP is also 
known as Vigilin due to the discovery of the chicken homolog in 1992 (Schmidt et al., 1992). The 
authors were not aware of the human homolog and therefore named the protein Vigilin based on the 
amino acids valine, isoleucine and glycine (VIG) reoccurring in the N-terminal part of the protein. 
HDLBP is conserved from yeast to human and ubiquitously expressed. Highest HDLBP mRNA 
expression in human tissues is found in secretory cells from e.g. the pancreas, the salivary gland or 


























Figure VII | HDLBP mRNA expression is highest in secretory tissue. Consensus normalized expression levels for the top
15 human tissues with highest HDLBP mRNA expression are shown. Data are taken from proteinatlas.org (as of October 
2020) where the transcriptomic datasets (GTEx, HPA, FANTOM5) were combined using a normalization pipeline. 
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Most characteristic for HDLBP are numerous hnRNP K homology (KH) domains. This domain was 
first discovered in hnRNP K, is highly conserved and comprises ~70 residues. The core motif of all 
KH domains is a minimal GxxG loop which is surrounded by alpha helices and ß sheets (Grishin, 
2001). In eukaryotes, there are 2 additional alpha and ß elements at the C-terminus, whereas 
prokaryotes have additional elements N-terminal to this core motif (Nicastro et al., 2015). The GxxG 
loop typically allows binding of 4 unpaired bases of single-stranded DNA or RNA with micro molar 
affinity. Multiple copies of KH domains are believed to achieve more specificity of nucleic acid binding 
by for example producing larger binding sites (Valverde et al., 2008). Moreover, there are 
endogenous KH domains that have altered or interrupted GxxG core motifs which are classified as 
divergent KH domains and which most likely mediate protein interactions. Overall, 38 human RNA-
binding proteins are annotated as KH domain containing protein and besides HDLBP all of them 
contain 1 to maximum 4 KH domains (RNA-binding protein database (rbpdb.ccbr.utoronto.ca) as of 
October 2020). In contrast, HDLBP has 15 KH domains making it an outstanding member of the KH 
domain family. Furthermore, HDLBP is also one of the largest RNA-binding proteins with a molecular 
mass of ~160 kDa. Human and mouse HDLBP contain 12 classical and 3 divergent KH domains 
(Figure VIII). Initially, HDLBP was reported to have 14 KH domains, but another divergent KH domain 
was found in the N-terminal part of the protein and numbered KH 0 (Cheng and Jansen, 2017). The 
structure of 7 human HDLBP KH domains is solved by crystallography (Protein database (rcsb.org) 
as of October 2020). The yeast homolog of HDLBP is called SCP160, has been intensively studied (see 
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Figure VIII | Schematic overview of the KH domain composition of HDLBP and its yeast homolog SCP160. Figure was 
adapted from Cheng and Jansen, 2017. 
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Functions  
Over the last decades of HDLBP research multiple functions of HDLBP and its homologs have been 
proposed. Even though there is no consensus about the exact function of HDLBP, there is no doubt 
that HDLBP binds nucleic acids. Most studies focus on the binding capacity of HDLBP to different 
types of RNA. Therefore, HDLBP is reported to influence many stages of RNA metabolism like tRNA 
and mRNA transport, translation or mRNA degradation. An overview of all the proposed functions of 
HDLBP can be found elsewhere (Cheng and Jansen, 2017). Here, we will summarize selected studies 
that illustrate what makes HDLBP a good candidate to be involved in the secretory pathway. These 
studies were mainly conducted in yeast and indicate on the hand that HDLBP contributes to ER mRNA 
targeting and on the other hand suggest that HDLBP is involved in translation regulation.  
 
The role of HDLBP in mRNA transport to the ER 
Only little direct evidence exists that HDLBP is involved mRNA targeting to the ER. However, it was 
shown for one selected Scp160p target that upon Scp160p deletion the mRNA signal was shifted from 
the membrane to the soluble fraction (Li et al., 2003). For another Scp160p target, it was observed 
that in pheromone-treated cells Scp160p was responsible for the correct localization of its target to 
the yeast-mating projection (shmoo) tip where it co-localizes with the cortical ER (Gelin-Licht et al., 
2012). Furthermore, it was revealed that Scp160p binds to several mRNAs encoding polarity, 
secretion and mating factors and it was demonstrated that Scp160p mediates pheromone gradient 
sensing and mating response (Gelin-Licht et al., 2012). Nevertheless, it is unknown whether this is 
mechanistically due to targeting specific mRNAs to the cortical ER.  
 
The role of HDLBP in translation regulation  
Several studies in S. cerevisiae suggest that Scp160p associates with polyribosomes pointing to a 
function of HDLBP in translation regulation (Baum et al., 2004; Brykailo et al., 2007; Hirschmann et 
al., 2014; Lang and Fridovich-Keil, 2000; Lang et al., 2001; Li et al., 2004). Moreover, it was reported 
that Scp160p interaction with polyribosomes is mRNA dependent and that Scp160p -ribosome 
complexes are located at the ER (Frey et al., 2001). This is in agreement with the observation that 
Scp160p is associated with membrane-bound ribosomes (Weber et al., 1997) and suggests that 
Scp160p acts as an RNA-binding platform interacting with polyribosomes that are transported to the 
ER (Frey et al., 2001).  
 
To uncover the role of Scp160p in translation, polysome profiling was performed upon Scp160p 
depletion and interestingly no global shift in translation was observed (Hirschmann et al., 2014). 
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Instead, Hirschmann et al. proposed that Scp160p controls the association of a specific subset of 
mRNAs with ribosomes and heavy polysomes. For one selected Scp160p target the study showed 
that Scp160p depletion led to translation downregulation and at the same time resulted in increased 
association with polysomes. It therefore seems that Scp160p  is important for translation elongation 
(Hirschmann et al., 2014). In addition, a decrease for some ribosome-associated tRNAs was observed 
upon Scp160p depletion suggesting that Scp160p prevents the diffusion of discharged tRNAs or 
influences tRNA recharge (Hirschmann et al., 2014) which consequently affects translation.  
 
Apart from these yeast studies, also a study using mice as a model organism showed that HDLBP 
influences translation. Moreover, this study revealed a role for HDLBP in liver metabolism (Mobin et 
al., 2016). Mobin et al. found in mouse hepatocytes that HDLBP binds to CU-rich regions in a subset 
of mRNAs encoding secreted proteins and enhances their translation. Direct evidence for this 
hypothesis was provided by in vitro translation assays whereby decreased translation of one HDLBP 
target (fetuin-A) was observed in HDLBP knockdown conditions. That resulted downstream in less 
production of feutin-A and subsequently in less secretion. Furthermore, less secretion of several 
other proteins was detected upon HDLBP knockdown and outstandingly also the secretion of VLDL 
(very-low-density lipoprotein) was decreased. VLDL is produced in the liver and mainly consists of 
apolipoproteins, cholesterol and triglycerides. It is transporting lipids throughout the body and a 
high blood level of VLDL is a known risk factor for cardiovascular diseases. To demonstrate the 
therapeutic potential of HDLBP Mobin et al. investigated the effect of hepatic HDLBP knockdown in 
in atherosclerosis prone Ldlr -/- mice. Importantly, they observed less atherosclerotic plaques upon 
hepatic HDLBP knockdown in Ldlr -/- mice showing that HDLBP is a promising target for 
cardiovascular research. 
 
Taken together, several studies suggest that HDLBP is involved in translation regulation and 
especially Mobin et al. demonstrated that HDLBP influences the secretory pathway and showed that 
HDLBP enhances the translation of one mRNA target. However, the global effect of HDLBP on 
translation particularly in humans remains uncertain and to further exploit the therapeutic potential 
of HDLBP it is necessary to fully characterize its role in translation and the secretory pathway.  
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Disease relevance  
As described above, HDLBP is a promising target for cardiovascular disease because it seems to 
influence the hepatic secretion of key lipoproteins like VLDL (Mobin et al., 2016). Furthermore, 
Mobin et al. reported that HDLBP is upregulated in livers of obese mice and in patients with fatty 
liver disease.  
 
Moreover, it was shown that HDLBP is overexpressed in hepatocellular carcinoma and required for 
human hepatocellular carcinoma cell proliferation and tumor growth (Yang et al., 2014). Apart from 
hepatocellular carcinoma, HDLBP is also associated with lung adenocarcinoma (Kim et al., 2015), 
chronic myeloid leukemia (Cha et al., 2016) and breast cancer (Woo et al., 2011). Kim et al. sequenced 
5 lung adenocarcinoma samples and found 2 samples with HDLBP mutations. Cha et al. analyzed by 
microarray chronic myeloid leukemia samples of 73 therapy responders and 38 non responders and 
found that HDLBP is differentially expressed between both groups suggesting that HDLBP might be 
useful as a diagnostic marker. Woo et al. investigated factors that modulate the expression of the 
proto-oncogene CSF1R in breast cancer and found that HDLBP inhibits CSF1R expression by binding 
to the 3’UTR. Subsequently, it was shown that overexpression of HDLBP in breast cancer cell lines 
led to less invasive behavior suggesting that HDLBP may function as a tumor repressor (Woo et al., 
2011). Along these lines Molyneux et al. carried out a study to discover cancer genes by creating 
tumors with retroviral and transposon mutagenesis and found HDLBP as a candidate tumor 
repressor (Molyneux et al., 2014). Additional analysis revealed that there are 98 known mutations 
within HDLBP in patients with cancer and that HDLBP was commonly lost in several cancer types 
(Molyneux et al., 2014). Knockdown of HDLBP in human sarcomas cells resulted in higher induction 
of tumor development further supporting that HDLBP might act as a tumor repressor (Molyneux et 
al., 2014).  
 
In addition, Felder and colleagues found out that HDLBP is down regulated in patients with autism 
and 2q37.3 deletion syndrome (Felder et al., 2009). Recently, Satterstom et al. identified in a large-
scale exome sequencing study 102 genes that are associated with autism spectrum disorder and 
found among these genes HDLBP (Satterstrom et al., 2020).  
 
Furthermore, HDLBP has been also associated with virus infection (Ooi et al., 2019). Ooi et al. 
screened for RNA-binding proteins that interact with the RNA of dengue and Zika viruses. Both 
viruses belong to the family of flavivirus and replicate in close association to the ER. HDLBP was 
discovered to interact with the viral RNA at the ER und it was suggested that HDLBP promotes 




AIMS OF THE THESIS 
The secretory pathway is essential for proper cell functioning and besides the well-established key 
points of the pathway, several mechanistic details are not completely understood. Especially the first 
steps of the pathway, where mRNAs encoding secretory and membrane proteins are targeted to and 
translated at the ER, remain to be further investigated. Fundamental questions like how are mRNAs 
transported to the ER and how is translation regulated at the ER are not fully answered yet.  
Previous studies in yeast and mice suggested that the RNA-binding protein HDLBP contributes to 
these processes. The aim of this thesis is to characterize the human HDLBP and to understand its 
function.  
 
Specific aims are: 
 To identify RNAs bound to HDLBP  
 To identify possible interactors of HDLBP  
 To understand the role of HDLBP in transporting its targets to the ER  
 To understand the role and function of HDLBP in translation  
 
To study the function of HDLBP, we will use a variety of genomic and proteomic approaches applied 
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RESULTS 
[1] Overview of generated cell lines 
To study the function of HDLBP, we used as a cell culture model system the human embryonic kidney 
cell line HEK293 Flp-In T-Rex (HEK293). This cell line allows to easily generate stable cell lines with 
inducible expression of the protein of interest.  
We made use of affinity tagging of HDLBP and generated HEK293 stable cell lines expressing either 
BirA-FLAG-HDLBP or FLAG/HA-HDLBP by hygromycin selection (Gregersen et al., 2014). The stable 
cell line stably expressing BirA-Flag-HDLBP was used for BioID experiments (see chapter 6). For 
PAR-CLIP, immunoprecipitation and polysome profiling experiments, we took advantage of the cell 
line stably expressing FLAG/HA-HDLBP (see chapter 2, 6, 8).  
For most other experiments we used HEK293 HDLBP knockout (HDLBP KO) cell lines in comparison 
to wild-type (WT) HEK293 cells. HDLBP KO cell lines were generated with the CRISPR-Cas9 system 
using two different guide RNAs. Guide RNA 1 (gRNA1) targeted exon 11 and guide RNA 2 (gRNA2) 
targeted exon 4.  
To understand the impact of HDLBP on cancer biology, we used as a cell culture model system the 
lung carcinoma cells A549 (see chapter 11). We also generated A549 HDLBP knockout cells, but only 
guide RNA 2 resulted in surviving colonies.  
Overall, A549 and HEK293 HDLBP KO cells were viable showing that HDLBP is a non-essential 
protein in both cell types which is consistent with findings from human chronic myelogenous 
leukemia cells (KBM7) (Blomen et al., 2015; Wang et al., 2015) and human hepatoma cells (Huh 7.5.1) 
(Ooi et al., 2019). 
Western Blot analysis of all cell lines used in this study is shown in Figure 1.  
 
Figure 1 | All HEK293 and A549 cell lines used in this study are shown. Western Blot analysis was 
performed with a primary antibody against HDLBP and an anti-tubulin antibody was used as a 
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[2] HDLBP is a cytoplasmic protein in HEK293 cells that co-localizes with the ER 
To determine function of HDLBP, we first investigated the subcellular distribution of HDLBP in our 
human cell system, in HEK293 cells. Previous findings suggest that HDLBP is a cytoplasmic protein 
(Neu-Yilik et al., 1993) and the human protein atlas lists the main localization of HDLBP as cytosol 
which is supported by immunohistochemistry data from A-431 cells (epidermoid carcinoma cells) , 
U-2 OS cells (osteosarcoma cells) and U-251 MG cells (glioblastoma cells) (proteinatlas.org as of 
October 2020). It was shown that HDLBP also co-localizes with the ER in Huh 7.5.1 cells (hepatoma 
cells) (Ooi et al., 2019) and in HEK293 cells (Lu et al., 2012). Besides that, a small fraction of HDLBP 
was also reported to be present in the nucleus (Kügler et al., 1996; Vollbrandt et al., 2004; Wang et 
al., 2005; Zhou et al., 2008).  
To clarify the localization of HDLBP in our cell system, we performed immunohistochemistry 
experiments using an antibody against HDLBP in combination with an ER-tracker and Hoechst 
nucleus staining. We show that HDLBP is localized in cytoplasm of HEK293 cells and also co-localizes 
with the ER (Figure 2).  
In addition, we carried out cell fractionation studies 
where we biochemically separated the cytoplasmic 
and membrane fraction (see chapter 4 for details). 
To confirm that this separation worked, we analyzed 
the localization of marker proteins with known 
localization (ER: BCAP31, cytosol: Tubulin) and 
found that the marker proteins distributed as 
expected (Figure 3). HDLBP was present in both 
fractions and enriched in the membrane fraction.  
We conclude that HDLBP is a cytoplasmic protein in 
HEK293 cells that co-localizes with the ER.  
Figure 2 |  Representative immunohistochemistry pictures of HEK293 cells stained with HDLBP (green), ER-tracker 
(red) and Hoechst (blue) showing that HDLBP is a cytoplasmic protein that co-localizes with the ER. 
 
 
Hoechst ER-RFP HDLBP-GFP Merged
Figure 3 | Western Blot analysis of cell 
fractionation purity using marker proteins (ER: 
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[3] HDLBP-bound mRNAs encode membrane and secretory proteins 
In the interest of understanding the function of the RNA-binding protein HDLBP it is crucial to 
identify RNA targets of HDLBP. Previously, it was shown that the mouse homolog of HDLBP mainly 
binds mRNAs encoding secretory proteins in hepatocytes which may have therapeutic potential for 
cardiovascular diseases (Mobin et al., 2016). To further exploit this therapeutic potential, we 
characterized the RNA targets of the human HDLBP by PAR-CLIP and validated our findings by 
immunoprecipitation experiments in combination with real-time PCR. 
 
HDLBP PAR-CLIP  
To identify direct RNA targets of HDLBP, we performed PAR-CLIP (Hafner et al., 2010) using a 
HEK293 cell line that stably expressed FLAG/HA tagged HDLBP (see chapter 1, Figure 1). We 
observed a similar expression level of FLAG/HA tagged HDLBP compared to endogenous HDLBP. 
Nascent RNA of these cells was metabolically labelled with 4-thiouridine (4sU) and by UV 
crosslinking the proteins were covalently linked to the labelled RNA. HDLBP-RNA complexes were 
immunopurified, radiolabeled and gel separated (Figure 4). HDLBP-bound RNA fragments were 
extracted, ligated to linkers and converted to a cDNA library. The 4sU incorporation caused T-to-C 
conversions during reverse transcription which allowed us to specifically identify HDLBP 
crosslinking sites on the target RNAs. Illumina sequencing of 2 PAR-CLIP replicates was carried out 
and after processing the reads, we only kept reproducible read clusters.  
We observed as expected a high frequency of T-to-C conversions. To obtain a HDLBP PAR-CLIP 
enrichment value per gene, we summed up all reproducible T-to-C conversions per gene and 
corrected this value for expression level bias. In addition, we assessed the distribution of T-to-C 
conversions within the 5’ untranslated regions (5’UTR), the coding sequence (CDS) and the 3' 
untranslated regions (3'UTRs) of mRNAs.  
 
 
Figure 4 | Experimental outline of the PAR-CLIP protocol with an autoradiograph of 32P-labeled RNAs crosslinked to 
HDLBP. 
 















replicate 1 replicate 2
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We found that the majority of T-to-C conversions (~50%) was present in the CDS of mRNAs (Figure 
5A). Around 20% of crosslinking signal was detected in 3'UTRs. We also identified crosslinks to the 
5’UTR, ribosomal RNA (rRNA), transfer RNA (tRNA) and SRP-RNA (7SL RNA). A minority of reads 
was detected in introns and intergenic regions.  
To characterize HDLBP-bound mRNAs, we compared HDLBP PAR-CLIP binding enrichment for 
different mRNA classes based on the presence of known targeting signals in corresponding proteins 
(Figure 5B). For cytosolic, mitochondrial or tail anchored transmembrane mRNAs we did not detect 
HDLBP binding enrichment. Modest HDLBP binding enrichment was observed for membrane-bound 
mRNAs with no known targeting signal (TS). In contrast, we found highest HDLBP binding 
enrichment for mRNAs encoding a signal peptide (SignalP) or transmembrane domains (TM) or both.  
 
 
Figure 5 | HDLBP mainly binds the CDS of mRNAs that encode a signal peptide (SignalP) or a transmembrane domain 
(TM) or both. (A) Distribution of HDLBP binding sites (T-to-C transitions) in different RNA-species. (B) HDLBP PAR-
CLIP binding enrichment for several mRNA classes.  
 
PAR-CLIP validation  
To validate the PAR-CLIP findings, we carried out RNA immunoprecipitation (RIP) experiments. 
Therefore, we used as well HEK293 cells stably expressing FLAG/HA tagged HDLBP (see chapter 1, 
Figure 1). For immunoprecipitation beads were coupled to either FLAG antibody or to an IgG control. 
FLAG/HA tagged HDLBP and its associated RNAs were enriched and the RNA was isolated. The RNA 
was reverse transcribed and detected by real-time PCR. Several HDLBP mRNA targets showed as 
expected high enrichment, whereas our HDLBP non-target control, a mitochondrial DNA encoded 
mRNA (MT-CO1), showed no enrichment (Figure 6). Characteristics of the validated HDLBP mRNA 
targets and their cellular mRNA localization (see chapter 4) are shown in Table 1. In addition, we 
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the crosslinking signal detected by PAR-CLIP results from stable interactions of HDLBP with its RNA 
targets.  
 
Gene mRNA localization (our data) Feature 
ATP1A1 membrane 10 transmembrane domains 
ATP1A3 membrane 10 transmembrane domains 
CD46 membrane 1 transmembrane domain 
CD71 / TFRC membrane 1 transmembrane domain 
HNRNPUL1 cytosol - 
IGF2R membrane 1 transmembrane domain 
LAMB1 membrane signal peptide  
LAMC1 membrane signal peptide 
PFN1 cytosol - 
TMBIM6 membrane 6 transmembrane domains 
YWHAZ cytosol - 
 





Figure 6 | Fold enrichment (anti-FLAG vs. IgG control) for several HDLBP targets and a negative control (MT-CO1) as 
detected by real-time PCR. The average of 4 replicates is shown and the corresponding standard deviation as indicated 
by the error bar. 
Taken together, we obtained a deep HDLBP PAR-CLIP data set which we validated by 
immunoprecipitation coupled with real-time PCR. We found that HDLBP binds several RNA species 
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[4] HDLBP interacts with ~80% of all ER-localized mRNAs 
HDLBP mRNA targets mainly encode for secretory and TM containing proteins and are known to be 
localized and translated at the ER. We next wanted to understand to which extent HDLBP is binding 
ER-localized mRNAs. Previously, it was reported that the mouse homolog of HDLBP is only binding a 
specific subset (17,5%) of mRNAs encoding secretory proteins in hepatocytes (Mobin et al., 2016).  
However, the specificity of HDLBP in human and non-secretory tissue is unknown.  
 
Here, we performed cell fractionation experiments and mRNA sequencing to first classify ER- and 
cytosol-localized mRNAs. The experimental outline is shown in Figure 7. We biochemically separated 
the cytoplasmic and membrane fraction by sequential detergent extraction (Jagannathan et al., 
2011). Cells were first permeabilized with a digitonin containing buffer. This allowed to specifically 
solubilize the plasma membrane because digitonin is a ß-sterol binding detergent and the plasma 
membrane has a higher cholesterol content compared to other membranes. The ER and nuclear 
membranes stayed intact and only the cytosolic components were collected. Next, a NP-40 containing 
buffer was used to further solubilize the ER and mitochondria membranes but leaving the nuclei, the 
intermediate filament network and the actin cytoskeleton intact which allowed us to collect the 
membrane fraction.  
We confirmed the successful separation of cytosol and membrane fractions by Western Blot analysis 
of proteins with known localization (see chapter 2, Figure 3, ER marker: BCAP31, cytosol marker: 
Tubulin). RNA was isolated from both fractions and in addition from non-fractionated (total) cells. 
RNA-sequencing libraries were prepared and sequenced. A principal component analysis was carried 
and showed that membrane, cytosol and total fractions are separated from each other as expected 
(Figure 8A). Replicate samples were highly reproducible as shown in the correlation matrix 



















Figure 8 | Quality control of the cell fractionation experiment in combination with RNA-sequencing. (A) Principal 
component analysis using variance stabilized transformation of RNA-sequencing read counts per gene. (B) Correlation 
matrix of pairwise comparisons between non-transformed RNA-sequencing read counts per gene derived from cytosol, 
membrane or total fractions. The Pearson coefficients are shown. 
 
 
We found mRNAs enriched in the cytosol and in the membrane fractions which enabled us to classify 
mRNAs according to their localization (Figure 9A). In total we classified 7292 mRNAs: 6135 cytosol-
localized mRNAs and 1157 membrane-localized mRNAs. 193 mRNAs did not show specific 
enrichment for any compartment. As described above the membrane fraction includes mRNAs 
localized at the ER membrane but in addition also mitochondrial mRNAs.  Therefore, we filtered our 
1157 membrane-localized mRNAs for mitochondrial encoded mRNAs. We found that all 13 protein 
coding mitochondrial mRNAs (Barchiesi and Vascotto, 2019) were, as expected, highly enriched in 
our membrane fraction. Overall, our membrane fraction mainly consists of ER-localized mRNAs 
(despite the 13 mitochondrial mRNAs) and in consequence we also use the term ER-localized mRNAs.  
To further explore our defined groups, we analyzed them for the enrichment of mRNAs that encoded 
or lacked co-translational targeting signals. We found highly enriched in the ER-localized mRNA class 
as expected mitochondrial DNA encoded proteins, mRNAs encoding a SignalP or TM and mRNAs 
encoding both (SignalP and TM) (Figure 9B). In contrast, mRNAs encoding post-translationally 
targeted tail-anchored transmembrane proteins and mRNAs encoding nuclear DNA encoded 
mitochondrial proteins were not enriched in the membrane fraction as expected giving us high 
confidence about our classification.  
To determine the localization of HDLBP mRNA targets, we plotted HDLBP crosslinking signal (T-to-
C conversions) versus the mRNA abundance in order to normalize for the expression level. We 
colored each mRNA according to our classification (orange = ER-localized, blue = cytosol-localized) 
(Figure 9C). Strikingly, strong HDLBP mRNA targets were mainly ER-localized. We estimated that 
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In summary, we obtained a high quality mRNA sequencing data set of fractionated HEK293 cells 
which allowed us to estimate that HDLBP binds more than 80% of all ER-localized mRNAs.  
 
 
Figure 9 | HDLBP binds to ~80% of all ER-localized mRNAs.  
(A) Quantification of steady state membrane and cytosolic localization of mRNAs by cell fractionation experiments in 
combination with RNA-sequencing. The histogram shows the log2-transformed membrane enrichment which was 
defined as the ratio between membrane versus cytosolic read counts only including mRNA with a TPM of at least 10. 
Membrane bound/ER-localized mRNAs (n=1557) and cytosolic mRNAs (n=6135) were classified using cutoffs of 0.5 
and 1.5 (grey lines).  
(B) Quality control of RNA-sequencing derived classification of mRNA localization. Log2-transformed membrane 
enrichment is shown for different mRNA classes which were defined according to published data (see Materials and 
Methods “Targeting signal annotations”).  
(C) Scatter plot of expression-normalized HDLBP PAR-CLIP CDS crosslinking signal versus mRNA expression level in 
non-fractionated/total cells. Each dot represents an mRNA and the color of the dots correspond to the mRNA localization 
as classified in (A). Membrane-localized mRNAs are shown in orange and cytosol-localized mRNAs are colored in blue.  
(D) HDLBP binding to membrane and cytosolic mRNAs as classified in (A). Percentages and absolute numbers of HDLBP 
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[5] HDLBP binds to a CU-containing motif in the CDS of ER-localized mRNAs and forms 
multivalent interactions  
After defining mRNA targets of HDLBP, we next wanted to understand the binding preferences of 
HDLBP within mRNA transcripts. Previously, it was reported that RNA recognition elements of the 
mouse homolog of HDLBP are a tandem of CHHC or CHYC (H = A/C/U and Y = C/U) spaced by 2-8 nt 
occurring evenly distributed along the CDS as determined by PAR-CLIP of primary hepatocytes 
(Mobin et al., 2016). In vitro assays using the xenopus homolog of HDLBP and the human HDLBP 
identified the binding motif as (A)nCU and CU(A)n within a 75 nt long single stranded region 
(Kanamori et al., 1998). However, the detailed binding characteristics of the human HDLBP are 
unknown.  Here, we show the binding preferences of HDLBP within mRNA transcripts, we uncover 
the binding motif of HDLBP, investigate HDLBP binding to longer RNA recognition elements and 
characterize multivalent HDLBP interactions.    
 
Binding preferences of HDLBP within mRNAs 
To assess the binding preferences of HDLBP from our PAR-CLIP data, we first normalized the 
reproducible T-to-C conversions within cytosol- and ER-localized mRNA targets for the library size. 
Next, we grouped the HDLBP crosslinks according to their occurrence in 5'UTR, CDS and 3'UTR. This 
grouping was highly reproducible between replicates (Figure 10) ensuring us that we can extract 
binding preferences of HDLBP from the PAR-CLIP data.   
 
Figure 10 | PAR-CLIP derived T-to-C conversions within mRNA transcript regions are highly reproducible between 
replicates. Scatter plots show normalized T-to-C conversions per million for 2 HDLBP PAR-CLIP replicates as detected 
in the 5’UTR, CDS and 3’UTR. The Pearson correlation coefficients are shown.  
Subsequently, we generated a high resolution map of HDLBP crosslinks within transcript regions of 
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to-C conversions per million reads and plotted at each position the mean scaled T-to-C signal. We 
observed more 5'UTR HDLBP binding in cytosol-localized mRNAs but overall we only detected less 
than 5% of HDLBP crosslinks in the 5'UTR (chapter 3, Figure 5A). Interestingly, we found that HDLBP 
predominantly binds all over the CDS of ER-localized mRNAs. In contrast, HDLBP binding to the 
3'UTR was more prevalent in cytosol-localized mRNAs.  
 
 
Figure 11 | HDLBP binds ER-localized mRNAs all over the CDS. Meta-transcript analysis of HDLBP crosslinking signal 
for cytosol-localized mRNAs (blue) and ER-localized mRNAs (orange) as classified by cell fractionation experiments in 
combination with RNA-sequencing (chapter 4).  
 
To further characterize HDLBP binding to the CDS versus 3'UTR, we analyzed the ratio between 
length-normalized T-to-C conversions detected in the CDS versus 3'UTR in ER- versus cytosol-
localized mRNAs. ER-localized HDLBP mRNA targets showed higher CDS/3'UTR ratios compared to 
cytosol-localized mRNA targets (Figure 12A).  
To understand where we detected most of the HDLBP crosslinking signal, we defined similar sized 
groups of ER- and cytosol-localized mRNA targets. Groups were composed of mRNAs with high (T-
to-C conversions > 1.39), mid (T-to-C conversions 0.3 – 1.39) and low (T-to-C conversions < 0.3) 
HDLBP crosslinks. The CDS versus 3'UTR ratio of each group was plotted and showed that most 
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In order to support this global analysis, we selected an ER-localized (IGF2R) and a cytosol-localized 
(HNRNPUL1) HDLBP mRNA target (also validated by real-time PCR, see Figure 6) and visualized the 
PAR-CLIP read coverage and T-to-C conversions (Figure 13). For the cytosol-localized mRNA 
HNRNPUL1, we detected on average equal read coverage in the CDS and 3'UTR. The ER-localized 
HDLBP target IGF2R showed high read coverage in the CDS confirming our conclusion that HDLBP 
predominantly binds the CDS of its ER-localized mRNA targets.  
 
Figure 13 | Browser representation of HDLBP PAR-CLIP read coverage and T-to-C conversions for IGF2R mRNA 
(membrane-bound HDLBP target) and HNRNPUL1 mRNA (cytosolic HDLBP target).  Figure 12 
 
Figure 12 | HDLBP mainly binds the CDS of ER-localized mRNAs. (A) Scatter plot of the CDS/3’UTR ratio of HDLBP
crosslinks plotted against total HDLBP crosslinks (membrane mRNAs = orange, cytosol mRNAs = blue). (B) Groups with
high, mid and low HDLBP crosslinks were plotted against the distribution of the CDS/3’UTR ratio.  Figure 13 
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Binding motif of HDLBP 
Next, we wanted to identify primary sequence characteristics of HDLBP binding. Therefore, we 
generated for each crosslinking position 7-mers. These 7-mers were ranked by their frequency 
relative to all crosslinked 7-mers (Figure 14A). Interestingly, we observed most frequently 7-mers 
containing C and U primarily in the CDS of ER-localized mRNAs. Taking the top 5 identified 7-mers, 
we derived a HDLBP CU-containing binding motif (Figure 14B).  
To understand why HDLBP shows a specificity for CU-containing motifs in the CDS of ER-localized 
mRNAs, we determined the overall occurrence of these motifs. That clarifies if HDLBP binds the CDS 
of ER-localized mRNAs because these mRNAs in general contain more frequently CU-motifs.  
Therefore, we determined all possible 7-mers within the CDS of ER- and cytosol-localized mRNAs. 
These 7-mers were ranked by their frequency and compared to HDLBP crosslinked 7-mers. Top 
HDLBP-crosslinked 7-mers were not found among the top 7-mers transcriptome wide, but showed 
significantly higher occurrence in the CDS of ER-localized mRNAs in comparison to the CDS of 
cytosol-localized mRNAs (Figure 15). Consequently, the binding preference of HDLBP to CU-
containing motifs in the CDS of ER-localized mRNAs can be explained by the sequence composition 
of ER-localized mRNAs which is different from cytosolic mRNAs.  
 
 
Figure 14 | HDLBP mainly binds to CU-containing sequences.  
(A) The frequency of top 10 HDLBP crosslinked 7-mers are shown for membrane- and cytosol-localized mRNAs. Signal 
detected in the CDS is shown in blue and signal detected in the 3’UTR is shown in orange.  
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Figure 15 | ER-localized mRNAs contain more frequently HDLBP crosslinked 7-mers. Scatterplots of HDLBP crosslinked 
7-mer frequency versus the 7-mer frequency in the whole CDS of membrane-localized mRNAs (left) and cytosol-localized 
mRNAs (right). The top 20 crosslinked 7-mers are shown in different colors.  
 
Binding of HDLBP to longer RNA recognition elements (RREs) 
Furthermore, we investigated if HDLBP could recognize longer RREs. Therefore, we took the top 40 
HDLBP k-mers with a length between 4 and 12 nucleotides and compared their frequency in ER-
localized versus cytosolic mRNAs (Figure 16A). In general, we identified that crosslinked k-mers 
were more frequently found in ER-localized mRNAs compared to cytosolic mRNAs. Interestingly, the 
longer the k-mer the more frequently it was detected in ER-localized versus cytosolic mRNAs. 
Subsequently, 10-12 nt k-mers showed the greatest difference between ER-localized and cytosolic 
mRNAs. As a control, we performed the same analysis using all other k-mers and as expected did not 
observe any difference between ER-localized versus cytosolic mRNAs. Overall, long high affinity RREs 

































Figure 16 | ER-localized mRNAs contain long high affinity RREs for HDLBP binding. (A) Distribution of z-scores derived 
from differences in the frequency of all possible k-mers within the CDS of membrane-localized mRNAs and the 3’UTR of 
cytosol-localized mRNAs. This analysis was performed for each k-mer length (4-12) for the group of top 40 bound HDLBP 
crosslinked k-mers (left) and for all other k-mers (right). (B) Log10-transformed p-values of pairwise Wilcoxon rank 
sum test of z-scores calculated for the top 40 bound HDLBP k-mers as described in (A).  
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Multivalent interactions of HDLBP 
Since HDLBP contains 15 KH domains, we explored the possibility that HDLBP forms multivalent 
interactions meaning that HDLBP recognizes several RREs within a transcript that are interspaced 
by unbound nucleotides.  Therefore, we investigated a +40 nt / -40 nt region around all detected T-
to-C conversions and counted 4-mers. The 4-mers were ranked according to their frequency. We took 
the top 10 enriched 4-mers and binned the multivalency scores into 5 equally-sized categories (high, 
mid-high, mid-mid, mid-low or low) and correlated them to the crosslink strength (normalized T-to-
C conversions in the +40 nt / -40 nt region) (Figure 17A). Interestingly, we detected that regions with 
the highest 4-mer frequency showed high crosslinking signal. This suggests that multivalent HDLBP 
binding was common and gave rise to high affinity interactions.  
To further characterize multivalent HDLBP interactions, we investigated in more detail the 
multivalency bins that we generated. For the high and mid-high multivalency bins, we calculated for 
each nucleotide within the +40 nt / -40 nt region the percentage of crosslinking signal (total T-to-C 
conversions) (Figure 17B). Looking at the high multivalency bin, we found a specific crosslink 
upstream (-13 nt) of the crosslink in the CDS of ER-localized mRNAs and the 3'UTR of cytosolic 
mRNAs. In addition, we detected a specific crosslink downstream (+16 nt, +20 nt) of the crosslink in 
the mid-high multivalency bin in the CDS of ER-localized mRNAs and in the high multivalency bin in 
the 3'UTR of cytosolic mRNAs. Accordingly, we estimated that high affinity HDLBP sites are 
 
 
Figure 17 | HDLBP forms multivalent interactions. (A) HDLBP multivalency analysis was performed in +40/-40 nt 
regions around crosslinking sites. For the top 10 enriched 4-mers by frequency the multivalency scores were binned into 
5 equally-sized categories and compared to the total normalized T-to-C conversion signal over the +40/-40 nt regions. 
(B) Analysis of the percentage of total T-to-C conversions for every nucleotide position within the +40/-40 nt region for 
the highest and mid-highest multivalency bins (as defined in (A)). (C) Comparison of mean multivalency scores between 
membrane and cytosol-localized mRNAs in their CDS. A positive set (UUCU, 4-mer group consisting of top10 HDLBP 
crosslinked 4-mers) and a negative set (AAGU, 4-mer group with no HDLBP enrichment) was used. Occurrence of these 
4-mer groups were counted in 30-nt sliding windows. The mean score per transcript was computed and the mean 
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approximately 40 nt long and contain 3-4 RREs positioned several nucleotides apart and occur in the 
CDS of ER-localized mRNAs and the 3'UTR of cytosolic mRNAs.  
We further analyzed the frequency of potential HDLBP binding sites in ER-localized and cytosolic 
mRNAs. Therefore, we calculated within a 30 nt sliding window in the CDS of mRNA sequences the 
frequencies of specific 4-mers. One group (UUCU) consisted of HDLBP top 10 4-mers and the control 
group (AAGU) contained 4-mers that showed no HDLBP PAR-CLIP enrichment, but had a similar 
transcriptome frequency (Figure 17C). We found that the UUCU group was significantly more 
frequent in the CDS of ER-localized mRNAs compared to cytosolic mRNAs. In contrast, no such 
significant difference was observed in the AAGU control group. That shows that the CDS of ER-
localized mRNAs contains a high density of HDLBP RREs giving rise to multivalent interactions.  
 
Taken together, we identified that HDLBP predominantly binds to a CU-containing motif with a 
length of up to 12 nt in the CDS of ER-localized mRNAs and forms high affinity multivalent 
interactions giving rise to an estimated binding site of ~40 nt length containing 3-4 HDLBP RREs. In 
addition, ER-localized mRNAs and cytosolic mRNAs differ in their sequence composition since we 
detected in the CDS of ER-localized mRNAs more frequently HDLBP CU-containing binding motifs 
and overall a high frequency of high density HDLBP RREs.  
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[6] HDLBP interacts with the translational apparatus 
To understand the functional consequences of HDLBP binding to its mRNA targets, we characterized 
the cellular environment of HDLBP to identify interaction partners.  In a previous study, proximity-
based proteomics (BioID) of HDLBP and 118 other proteins was performed to uncover RNA 
regulatory structures (Youn et al., 2018). HDLBP was found to be in close proximity to 849 proteins 
involved in various cellular processes. In addition, several HDLBP interaction partners have been 
reported in the past decades of HDLBP research pointing in different directions depending on the 
proposed function of HDLBP (Cheng and Jansen, 2017). Here, we aim to characterize the cellular 
environment of HDLBP in HEK293 cells by first analyzing HDLBP RNA interactions and next 
determining HDLBP protein interactions.  
 
RNA interactions of HDLBP 
First, we further explored the PAR-CLIP data for HDLBP RNA interactions. Looking at HDLBP binding 
to rRNA, we identified 2 major binding sites located in helix 16 and expansion segment 6SB (Figure 
18A,B). Interestingly, these sites are in proximity of initiation and elongation factor binding sites 
which suggests that they have regulatory functions (Anger et al., 2013; Díaz-López et al., 2019).  
 
Figure 18 | HDLBP binds to rRNA mainly in helix 16 and expansion segment 6SB. (A) Browser representation of HDLBP
PAR-CLIP read coverage and T-to-C conversions for pre-ribosomal RNA. PAR-CLIP T-to-C conversions for IRE1 are shown
for comparison. (B) Structure of the human 80S ribosome (PDB: 4V6X) and the SRP-complex (PDB:3JAJ) were juxtaposed.
HDLBP crosslinks to rRNA and 7SL RNA are shown in red. 
 
In addition, HDLBP rRNA binding sites are in close proximity to SRP binding sites. We already showed 
that PAR-CLIP data suggest that HDLBP is binding to SRP RNA (7SL RNA) and we could confirm this 
by real-time PCR experiments (see chapter 3). Detailed PAR-CLIP analysis now revealed that HDLBP 
crosslinks to the small Alu region and to helices of the large (S) domain of 7SL RNA (Figure 19C). To 
better asses the specificity of HDLBP binding to these sites, we compared it with binding patterns of 
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other RBPs (IRE1, MOV10) (Figure 19A). We found that HDLBP binding to 7SL RNA is distinct from 
other RBPs. Furthermore, we compared the percentage of SRP crosslinks over total crosslinks in 
HDLBP PAR-CLIP data to other RBPs. We found that HDLBP showed similar levels of SRP crosslinks 
as IRE1 and SSB which are known or expected to interact with the SRP (Figure 19B) (Acosta-Alvear 
et al., 2018; Garzia et al., 2017; Gogakos et al., 2017). MOV10 is not expected to bind 7SL RNA and 
therefore showed 10 fold less binding to 7SL RNA compared to HDLBP.  
 
Figure 19 | HDLBP binds to RN7SL (SRP RNA). (A) Browser representation of HDLBP PAR-CLIP read coverage and T-to-
C conversions for SRP RNA. PAR-CLIP data for IRE1 and MOV10 are shown for comparison. (B) Percentage of total T-to-C
conversions detected in SRP RNA for HDLBP, SSB, IRE1 and MOV10. (C) Secondary structure of SRP RNA. HDLBP
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Taken together, PAR-CLIP data suggest that HDLBP interacts with the 40S subunit of the ribosome 
and the 7SL RNA of the SRP which is known to bind the ribosome in close proximity to the HDLBP 
ribosome binding sites. 
 
Protein interactions of HDLBP 
To further understand the cellular environment of HDLBP, we carried out in vivo biotinylation assays 
(BioID) (Couzens et al., 2013). The experimental outline is shown in Figure 20A. We used a 
doxycycline inducible cell line that stably expressed HDLBP fused with a biotin ligase at the N-
terminus (BirA-FLAG-HDLBP) (see chapter 1, Figure 1). After induction with doxycycline, biotin was 
added to the cells and all the proteins in close proximity to BirA were biotinylated. Next, those 
proteins were pulled down and analyzed by mass spectrometry. As a control we used the same 
protocol but excluded the doxycycline induction step. The experiment was carried out 3 times.  
  
 
Figure 20 | HDLBP BioID to detect potential protein interactors.  
(A) Overview of the BioID experiment. (B) Representative scatter plot of log2-transformed LFQ intensity in a doxycycline 
(Dox)-induced sample versus an un-induced (noDox) control sample. Enriched proteins (LFQ Dox/LFQ noDox>3 and 
log2(LFQ Dox)>27) are shown in red and the remaining detected proteins are shown in grey. (C) Reproducibility of the 
BioID experiment. The overlap between enriched proteins in 3 replicate experiments is shown in a Venn diagram. (D) 
Venn diagram shows the overlap of proteins in close proximity to HDLBP as detected in this study (N-terminal data) and 
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To define proteins in close proximity to HDLBP, we compared the doxycycline induced sample with 
the control (Figure 20B). Overall, we considered 249 proteins in close proximity to HDLBP since 
these proteins were present in all 3 replicates (Figure 20C). Comparing our data set to published 
BioID data obtained from a C-terminal fused biotin ligase HDLBP fusion protein ,we found an overlap 
of 140 proteins (Figure 20D) (Youn et al., 2018) suggesting that N- and C-terminal data sets 
correspond well.  
Our top 60 N-terminal BioID identified proteins are shown in Figure 21A. They were also identified 
in the published C-terminal BioID data set (except C1orf198 and VDAC1). Among our top 60 proteins 
we found a protein of the 40S subunit of the ribosome (RPS3A), a SRP protein (SRP68), proteins 
involved in translation initiation (EIF4G1, EIF4B, EIF5, EIF4E2), chaperones and chaperonins 
(HSPA1A, HSPA8, CCT8, HSPA5) and proteins involved in the organization of the cytoskeleton (FLNA, 
CORO1B, CTTN, FLNB). Top GO terms of the 249 identified proteins included translation and 
regulation of translation (Figure 21B). In summary, our BioID data suggest that HDLBP is involved in 
regulation of translation.  
To confirm the interaction of HDLBP with the 40S subunit of the ribosome as detected by PAR-CLIP 
and BioID experiments, we carried out co-immunoprecipitation experiments. Therefore, we used a 
cell line that stably expressed HDLBP tagged with FLAG/HA (see chapter 1, Figure 1). Anti-Flag along 
with control anti-IgG immunoprecipitation were carried out and input and eluate samples were 
analyzed by Western Blot analysis (Figure 21C). We found that HDLBP co-immunoprecipitated with 
RPS6, a component of the ribosomal 40S subunit of the ribosome. In contrast, only a little amount of 
a 60S ribosomal subunit component (RPL7) co-immunoprecipitated.  
 
In conclusion, these results suggest that HDLBP is interacting with the 40S ribosomal subunit and the 
translational apparatus including translation initiation, elongation factors and the SRP.  
 













Figure 21 | Proteins in close proximity to HDLBP are involved in translation.  
(A) Top 60 enriched proteins of the BioID experiment ranked according to the mean LFQ value from 3 replicates. The 
color of the dots corresponds to the mean LFQ value and the size of the dots correspond to the enrichment. Protein 
names labeled in orange are mentioned in the main text. 
(B) Gene Ontology enrichment of all enriched BioID proteins. Adjusted P values for the top 5 enriched categories and 
proteins corresponding to the top category are shown.  
(C) Co-immunoprecipitation of FLAG/HA-HDLBP with either anti-FLAG or IgG antibodies. Western Blot analysis of input 
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[7] HDLBP does not significantly influence the ER-localization of its mRNA targets  
Given the close proximity of HDLBP to proteins that are involved in the organization of the 
cytoskeleton, we hypothesized that HDLBP might be involved in mRNA transport to the ER. 
Previously, it was reported that the yeast homolog of HDLBP interacts with polysomes that are 
transported to the ER (Frey et al., 2001). However, the role of human HDLBP in mRNA transport is 
unknown.  
To uncover the influence of HDLBP on mRNA 
localization, we carried out cell fractionation 
experiments in combination with RNA-sequencing. The 
results of these experiments using HEK293 WT cells are 
described in detail in Chapter 4. Here, we performed the 
same experiment using both HDLBP KO cell lines 
(gRNA1 and gRNA2) and found as expected mRNAs 
enriched in the cytosol and membrane fractions. Next, 
we compared the membrane/cytosol ratio of each 
mRNA between WT and HDLBP KO cells. Assuming that 
HDLBP transports its targets to the ER, we would expect 
to encounter less mRNAs in the membrane fraction 
upon HDLBP KO. Contradictory, we found no significant 
differences comparing WT to HDLBP KO cells (Figure 22) suggesting that HDLBP is not involved in 
mRNA transport. Interestingly, one gene, HSPA5, which is also known as BiP, showed less enrichment 
in the membrane fraction upon HDLBP KO which caught our interest (Figure 22). BiP is an important 
chaperone and regulator of ER homeostasis. Previously, it was shown that mis-regulation of BiP  
leads to ER morphology defects (Li et al., 2008). Therefore, we hypothesized that slight mis-
regulation of BiP upon HDLBP KO could already cause ER morphology changes and corresponding 
phenotypes.  
To examine this hypothesis, we carried out electron microscopy and compared the ER morphology 
of HEK293 WT and HDLBP KO cells. We found that HDLBP KO cells show the same ER morphology 
as WT cells (Figure 23) suggesting that the slight effect on mis-localization of BiP mRNA upon HDLBP 
KO does not have consequences on ER morphology.  
 
























Figure 22 | HDLBP is not influencing the 
cellular localization of its mRNA targets. 
Scatterplot of the membrane/cytosol ratio of 
mRNAs in HEK293 WT vs HDLBP KO cells. 
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                                                    HDLBP KO g2  
 
 
Figure 23 | Representative electron microscopy images of HEK293 WT and HDLBP KO cells 
showing no ER morphology differences. Arrows indicate the ER.  
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[8] HDLBP promotes translation of its mRNA targets  
Given the interaction of HDLBP with the translational apparatus, we wanted to determine the role of 
HDLBP in translation. Previously, it was reported that the mouse homolog of HDLBP enhances the 
translation of a subset of mRNAs encoding secretory proteins (Mobin et al., 2016) and the yeast 
homolog of HDLBP was also described in several studies to function in translation regulation (Cheng 
and Jansen, 2017). However, the global effect of human HDLBP on translation remains uncertain. In 
order to investigate this, we carried out ribosome profiling, pulsed SILAC and polysome profiling. 
 
Ribosome profiling  
To determine the role of HDLBP in translation, we performed ribosome profiling (Ingolia et al., 2009) 
using 2 HEK293 HDLBP KO cell lines (gRNA1 and gRNA2)  in comparison to WT HEK293 cells (see 
chapter 1, Figure 1). The experimental outline is shown in Figure 24A. Cells were lysed with 
cycloheximide containing lysis buffer and treated with RNase I to enrich ribosome-protected 
fragments, which were ligated to linkers, converted to cDNA libraries and sequenced. To normalize 
the data, we also measured the mRNA abundance in the same cell lysates by RNA-sequencing. 
 
Figure 24 | (A) Overview of the ribosome profiling and RNA-sequencing experiment. (B) Representative analysis of in-
frame footprints for one ribosome profiling library. The percentage of P sites detected in the 3 possible frames within 
transcripts is shown in bar plots. (C) Scaled P site coverage is shown for 250 codons from the start codon. The scaled P 
site coverage was averaged over all CDSs and for smoothing a rolling mean over 10 nt was used. Signal from cytosolic 
mRNAs is shown in green, membrane-localized mRNAs containing a signal peptide (SP) or a transmembrane domain 





























0 1 2 0 1 2
5’UTR CDS 3’UTR























--   Results  --   44 
 
Ribosome profiling was carried out in replicates and after processing the reads, we identified as 
expected ribosome footprints enriched in the CDS showing a typical codon periodicity pattern 
(Figure 24B). Considering that we are especially interested to uncover the effect of HDLBP on its 
mRNA targets, which are mainly ER-localized, we asked if our ribosome profiling data set from non-
fractionated cells sufficiently captured ER-localized mRNAs. Therefore, we checked the footprint 
density of SP and TM containing mRNAs from the start codon to the region where the targeting signal 
(SP or 1st TM) emerged from the ribosome. We observed as expected low footprint density in that 
region confirming that we are able to capture the translation of ER-localized mRNAs with near-
nucleotide resolution (Figure 24C).  
To assess the influence of HDLBP on its ER-localized mRNA targets, we calculated the translation 
efficiency (TE) changes comparing HDLBP KO to WT (Figure 25A). Evaluating the TE changes has the 
advantage that both mRNA abundance and ribosome occupancy are taken into account. Furthermore, 
we defined for this analysis different similar sized groups of ER-localized mRNAs. Groups were 
composed of mRNAs with high, mid, low or no HDLBP crosslinks in the CDS as determined by PAR-
CLIP. Strikingly, we found that strong HDLBP mRNA targets (having high numbers of T-to-C 
conversions in the CDS) showed the highest decrease in TE upon HDLBP KO. We observed for mRNAs 
having mid numbers of HDLBP PAR-CLIP T-to-C conversions a modest decrease in TE upon HDLBP 
KO and we found no TE differences for low HDLBP mRNA targets and HDLBP non-targets. These 
results demonstrate that HDLBP promotes the translation of its target mRNAs.  
 
Figure 25 | HDLBP promotes the translation of its mRNA targets.  
(A) Differences in translation efficiency between HDLBP KO to WT cells are shown for different groups of ER-localized 
HDLBP targets. To test for significance, the Wilcoxon rank sum test was used.  
(B) Ribosome P site coverage around signal peptides (upper panel) and the 1st transmembrane domain (lower panel) 
was compared between HDLBP KO and WT cells. P site coverage was scaled to the coverage in codons 20-40 of each 
mRNA and a rolling mean of 5 nt was used to smooth the profiles. Median signal peptide and 1st transmembrane domain 
length are indicated with a vertical dotted line.  Absolute numbers of analyzed mRNAs are shown. 
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To further understand the interaction of HDLBP with its mRNA targets, we analyzed the footprint 
coverage around known targeting signals (Figure 25B). Therefore, we aligned mRNAs according to 
their targeting signal. The upper panel shows the average P site coverage 250 codons after the start 
of the signal peptide of 339 signal peptide encoding mRNAs. The lower panel shows the average P 
site coverage 100 codons before and 250 codons after the start of the first transmembrane domain 
of 587 mRNAs that encode at least one transmembrane domain. Interestingly, we found that the 
ribosome density downstream of the targeting signal region (SP or the 1st TM) is decreased upon 
HDLBP KO suggesting that HDLBP contributes to the translation arrest.   
 
pulsed SILAC 
The ribosome profiling experiments showed that the TE of HDLBP targets is decreased upon HDLBP 
KO suggesting that less proteins are synthesized. To confirm this, we carried out pulsed stable isotype 
labelling with amino acids in cell culture (pSILAC) (Schwanhäusser et al., 2009) in combination with 
cell fractionation to obtain the cytosol and membrane fraction. The experimental outline is shown in 
Figure 26. HDLBP KO and WT cells were grown in medium containing the “light” form of amino acids. 
Next, this medium was replaced by either medium containing the “heavy” form or the “medium” form 
of amino acids for 2 or 4 hours. Cells were fractionated as described in Chapter 4 and thereby WT 
and HDLBP KO cells (labeled with different forms of amino acids) were combined.  
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The heavy/medium ratios which recapitulate the newly synthesized proteins in HDLBP KO vs WT 
were calculated and proteins were grouped according to their mRNA localization and HDLBP binding 
(Figure 27A). We found a decrease in protein synthesis in the membrane fraction for proteins 
encoded by ER-localized mRNAs. Looking at proteins encoded by mRNAs that are strong HDLBP 
targets (based on the amount of T-to-C conversions in the CDS), we found as expected a reduction of 
protein synthesis (Figure 27B). The top 30 proteins with most decreased synthesis are shown in 
Figure 27C.  





Figure 27 | Proteins encoded by ER-localized mRNAs show decreased protein synthesis upon HDLBP KO.  
(A+B) pSilac analysis of newly synthesized proteins in the membrane fraction of WT and HDLBP KO cells. SILAC heavy 
vs. medium ratios (H/M) were quantified and reflect changes in protein synthesis upon HDLBP KO.  Wilcoxon rank sum 
test was used to compare SILAC ratios between different groups of HDLBP targets.  
(C) The top 30 proteins with most decreases in protein synthesis upon HDLBP KO as detected by pSILAC are shown. The 
sizes of the dots correspond to PAR-CLIP T-to-C conversion signal (left dot with solid outline) or to decrease in 
translation efficiency upon KO as detected by ribosome profiling (right dot dashed outline).  
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Polysome profiling 
To further define the role of HDLBP in translation, we carried out polysome profiling (Jagannathan 
et al., 2011). This technique is based on sucrose density centrifugation of the cell lysate which allows 
to separate free mRNAs, the 40S and 60S subunits of the ribosomes, the monosomes and the 
polysomes. Subsequent Western blotting of the separated fractions allows to visualize the 
distribution of the protein of interest. Previously, the yeast homolog of HDLBP was found to be 
enriched in the polysome fraction suggesting that its involved in translation regulation (Baum et al., 
2004; Brykailo et al., 2007; Frey et al., 2001; Hirschmann et al., 2014; Lang and Fridovich-Keil, 2000; 
Lang et al., 2001; Li et al., 2004). 
Here, we performed polysome profiling using a cell line that stably expressed HDLBP tagged with 
FLAG/HA (see chapter 1, Figure 1). After recording of the profile and collection of the fractions, we 
carried out TCA precipitation and Western Blot analysis (Figure 28). We found that HDLBP is 
enriched in fraction 1-6. In addition, we also detected HDLBP in the monosome fraction and in the 
polysome fractions 8-12. As positive controls, we used the ribosomal proteins RPS6 and RPL7 and as 
a negative control we used tubulin. All controls were distributed as expected.  
We conclude that human HDLBP mainly interacts with the ribosomal subunits, whereas the yeast 
homolog of HDLBP was mainly detected in the polysome fractions.  
 
Taken together, we show that HDLBP promotes the translation of its mRNA targets resulting in their 
efficient protein synthesis. Furthermore, we find evidence that HDLBP contributes to translation 
arrest. Polysome profiling experiments support the role of HDLBP in translation.  
 




Figure 28 | Polysome profiling shows that HDLBP is enriched in mRNPs and ribosomal subunits, but also associated 
with monosomes and polysomes.  
(A) Representative polysome profiling of FLAG/HA-HDLBP HEK293 cells.  
(B) Representative Western Blot analysis with TCA precipitated polysome profiling fractions. For fraction 3-12 all the 
material was used, whereas only 20% of fraction 1 and 2 were loaded. Fractions 13-15 and 16-20 were combined and 
an equal volume was loaded. A primary anti-HA antibody was used to detect FLAG/HA-HDLBP. Antibodies against 
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[9] HDLBP prevents global stalling 
To further characterize the impact of HDLBP on translation, we analyzed the ribosome occupancy 
per codon. During translation each nucleotide of a codon is bound by a ribosome at a designated site 
(A, P and E sites). Our ribosome profiling data allowed us to extract P site and E site coverage for each 
codon. Next, we compared the P site and E site occupancy between HEK293 WT and HDLBP KO cells 
(Figure 29). We found that various codons showed higher ribosomal occupancy in both P site and E 
site upon HDLBP KO suggesting that HDLBP absence leads to global stalling. Interestingly, highest 
ribosome occupied codons encoded for Phenylalanine (UUC, UUU) and Leucine (CUU). Those codons 
correspond to the identified HDLBP CU-containing binding motif (see chapter 5).  
 
Figure 29 | HDLBP KO leads to higher ribosome occupancy of various codons in both P Site and E site. The difference in 
codon frequencies in the P site (top) and E site codons (bottom) in HDLBP KO vs. WT are shown for each codon. Mean 
codon shift was calculated for four replicates and the mean standard deviation is shown by error bars. 
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To understand if HDLBP is indeed binding to these codons (UUC, UUU, CUU), we investigated the 
PAR-CLIP signal on codon level. This will clarify which codons are bound by HDLBP because the CU-
containing motif alone gives rise to a number of possible codons that could be bound by HDLBP. We 
counted T-to-C conversions for each codon per transcript, normalized to the transcript expression 
level and sorted the transcripts according to their membrane enrichment as determined by cell 
fractionation and RNA-sequencing (see chapter 4). We found that HDLBP most bound codons are 
UUC encoding for phenylalanine and CUC, CUU encoding for leucine for which we observed high 
ribosome occupancy upon HDLBP absence (Figure 30). Therefore, HDLBP binding on these codons 
might prevent stalling.  
 
Figure 30 | HDLBP mostly binds CU-containing codons. The normalized T-to-C conversions were counted for each 
codon per transcript and normalized to the transcript expression level. The heatmap shows transcripts (columns) 
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Ribosome stalling can be caused by mis-regulation of tRNA availability. We already identified codons 
that show stalling and therefore we can estimate which tRNAs could be less available. To understand 
the impact of HDLBP on those tRNAs, we further explored the PAR-CLIP data and characterized 
HDLBP binding to tRNAs. We counted the PAR-CLIP coverage for each tRNA and also investigated the 
position of T-to-C conversions within tRNAs (Figure 31). Interestingly, 4 Leucine isotype tRNAs were 
among the top 15 enriched tRNAs and we detected the crosslinking sites in the variable and D loops. 
The crosslinking sites corresponded to the identified HDLBP CU-containing motif (UCUUC). Codons 
decoded by these tRNAs showed high ribosomal occupancy upon HDLBP KO suggesting that HDLBP 
tRNA binding contributes to efficient tRNA decoding. 
 
Figure 31 | HDLBP binding to tRNAs. HDLBP PAR-CLIP detected T-to-C conversions in tRNAs were normalized to total 
tRNA abundance and ranked from the highest to the lowest value (left to right). For each T-to-C conversion the conversion 
specificity (T-C transition vs. total read coverage) was displayed. On top the total log2-transformed tRNA abundance and 
codon usage are shown. 
 
In summary, codon level analysis of ribosome profiling and PAR-CLIP data revealed that HDLBP KO 
leads to higher ribosomal occupancy for various HDLBP bound codons suggesting that HDLBP 
prevents global stalling. Moreover, we identified that HDLBP binds tRNAs that decode these codons 
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[10] HDLBP promotes secretion and transmembrane protein abundance 
Since HDLBP promotes the translation and synthesis of several secretory and membrane proteins, 
we wanted to determine the effect of HDLBP on secretion and membrane insertion per se. Previously, 
it was shown that HDLBP influences the secretion of certain proteins from primary mouse 
hepatocytes (Mobin et al., 2016). However, the effect of human HDLBP on secretion and in non-
specialized secretory cells is unknown. Moreover, the impact of HDLBP on membrane insertion is 
unexplored.  
 
The influence of HDLBP on secretion 
To study secretion in HEK293, we used reporter proteins because a global mass spectrometry based 
assessment of all proteins secreted from HEK293 cells resulted in non-quantifiable results (data not 
shown). As reporter proteins, we used secreted Gaussia luciferase (Gluc) and secreted alkaline 
phosphatase (SEAP). The experimental outline is shown in Figure 32. Gluc and SEAP were transiently 
transfected into HEK293 WT and HDLBP KO cells. The enzyme activity was quantified in culture 
medium. In order to normalize for transfection efficiency and cell number differences, we co-
transfected non-secreted Firefly luciferase (Fluc) and quantified intracellular Fluc activity.  
 
Figure 32 | Overview of the Gluc/SEAP luciferase secretion assay. 
 
Next, we calculated the Gluc/Fluc and SEAP/Fluc ratio for WT and HDLBP KO cells. Gluc and SEAP 
activity were significantly decreased around 30% upon HDLBP KO (Figure 33A,B) showing that 
HDLBP promotes secretion.  
To prove that the reduced secretion effect in HDLBP KO cells was due to HDLBP absence, we 
performed rescue experiments. Therefore, we used HDLBP KO gRNA2 cells because here, we 
observed a slightly stronger secretion reduction in comparison to HDLBP KO gRNA1 cells. Moreover, 
SEAP was secreted less compared to Gluc in HDLBP KO gRNA2 and consequently we performed the 
SEAP assay using HDLBP KO gRNA2 cells in comparison to WT cells. The experiment was carried out 
as described above but in addition, we co-transfected HDLBP. We found that co-transfection of 
Nuc
WT and HDLBP KO cells
transient transfection 
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HDLBP resulted in more SEAP secretion in both WT and HDLBP KO cells (Figure 33C). Thus, we 
successfully rescued the phenotype and further demonstrate that HDLBP promotes secretion.  
 
 
Figure 33 | HDLBP promotes secretion of SEAP and Gluc. 
(A+B) Gluc activity (A) or SEAP activity (B) was quantified in cell culture medium and normalized to the intracellular 
Fluc activity. The average of 5 technical replicates per experiment is shown and the corresponding standard deviation 
as indicated by the error bar. 
(C) SEAP activity was quantified in cell culture medium and normalized to the intracellular Firefly luciferase activity. 
The average value of 5 SEAP rescue experiments with co-transfection of HDLBP is shown and the corresponding 
standard deviation as indicated by the error bar. For each of the 5 experiments at least 5 technical replicates were used. 
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The influence of HDLBP on membrane-protein surface expression 
To study the influence of HDLBP on membrane insertion, we chose to determine the surface 
expression of one HDLBP target TFRC also known as CD71. We already showed by PAR-CLIP and 
real-time PCR that TFRC mRNA is bound by HDLBP (see chapter 3). In addition, ribosome profiling 
showed that TFRC has a decreased translation efficiency upon HDLBP KO and pSILAC confirmed that 
less TFRC protein is synthesized in absence of HDLBP (see chapter 8). To quantify surface expression 
of TFRC, we stained WT and HDLBP KO cells with a TFRC flow cytometry suitable antibody and 
measured the mean fluorescent intensity (MFI) of the antibody signal by flow cytometry (Figure 
34A,B). We found that the relative MFI was significantly decreased around 25% upon HDLBP KO, 
whereas our control staining showed as expected no difference between HDLBP KO and WT.  
 
Figure 34 | TFRC shows less surface expression upon HDLBP KO.  
(A) Relative mean fluorescent intensity (MFI) of TFRC in WT and HDLBP KO cells as determined by flow cytometry 
experiments. The average of 4 replicates is shown and the corresponding standard deviation as indicated by the error 
bar. 
(B) Representative histograms of TFRC-APC (left) and an isotype-control (right) staining of WT and HDLBP KO cells.  
 
Overall, HDLBP influences the surface expression of membrane proteins whose mRNA it binds and 
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[11] HDLBP decreases tumor formation capacity in vivo 
To understand the impact of HDLBP on cancer biology, we established a HDLBP KO cell line in lung 
carcinoma cells A549 (see chapter 1, Figure 1). First, we analyzed the 2D growth characteristics of 
these cells in comparison to WT A549 cells. We found that HDLBP KO cells grew slower and were less 
viable (Figure 35A). Scratch migration assays showed that HDLBP KO cells had a reduced wound 
closure capacity (Figure 35B).  
 
Figure 35 | A549 HDLBP KO cells grow slower and are less viable compared to WT cells.  
(A) Relative confluence and viability of A549 WT or HDLBP KO cells was quantified and the left panel shows 
representative confluence masks. 
(B) Wound healing of A549 WT or HDLBP KO cells was quantified after 20 h post damage and the left panel shows 
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Next, we tested the tumor formation capacity of A549 HDLBP KO and WT cells in vivo. To this end, 
cells were stably transduced with infrared fluorescent protein (iRFP) and injected into 8 athymic 
nude mice. Tumor initiation and growth was measured 0, 7, 14 and 21 days post-injection (Figure 
36A,B). WT cells formed as expected tumors in all 8 animals, whereas HDLBP KO cells only formed 
tumors in 3 out of 8 mice. The tumor initiation, the tumor volume and weight was decreased upon 
HDLBP KO.   
 
 
Figure 36 | HDLBP decreases tumor formation capacity in vivo.  
(A) Non-invasive infrared RFP imaging of mice was carried out 0 days post-injection confirming that the same amount 
of A549 WT and HDLBP KO cells were injected (upper panel) and 21 days post-injection showing the tumors (lower 
panel).  
(B) The tumor volume was quantified 7, 14 and 21 days post injection (upper panel) and tumor weight was quantified 
after 21 days post injection (lower panel). For comparison between WT and HDLBP KO an unpaired t test was used and 
in case of tumor absence, the weight was plotted as 0. 
 
In conclusion, cell culture and in vivo experiments with HDLBP KO A549 cells revealed that HDLBP is 
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DISCUSSION  
The secretory pathway is essential for proper cell functioning and key steps of the pathway are well 
known. This also includes the first step of the pathway where mRNAs encoding membrane or 
secretory proteins are targeted to the ER mainly by the SRP. It is well-established that the SRP binds 
ER-targeted ribosome nascent chain complexes co-translationally in the cytosol. Subsequently, a 
translation arrest occurs and the complex moves to the ER where the translation continues and the 
nascent protein is translocated into the ER lumen (Zhang and Shan, 2014). However, several 
mechanistic details of the SRP cycle, especially regarding the translational arrest, remain 
incompletely understood. Furthermore, it is discussed if the mRNA sequence itself contributes to ER-
targeting. Interestingly, cis-acting regulatory sequence elements have been identified (e.g. Cohen-
Zontag et al., 2019), but no trans-acting factors such as RNA-binding proteins are characterized to 
specifically bind these elements and to influence ER-targeting. Moreover, it is not fully understood 
which factors contribute to translation regulation specifically at the ER.  
 
Based on previous studies, we hypothesized that the RNA-binding protein HDLBP is involved in these 
processes and characterized HDLBP by using a variety of transcriptomic and proteomic approaches 
and provide the most comprehensive study about the human HDLBP to date. Most importantly, we 
found that HDLBP influences the translation of its ER-localized target mRNAs. We estimated that 
HDLBP binds more than 80% of all ER-localized mRNAs by specifically recognizing a CU-containing 
motif and forming multivalent interactions. In addition, we discovered that ER-localized mRNAs per 
se differ from cytosol-localized mRNAs in their sequence composition since they contain more 
frequently CU-rich HDLBP binding sites. Therefore, we further defined regulatory sequence elements 
within ER-localized mRNAs and characterized the RNA-binding protein HDLBP, which binds to these 
elements, and thereby influences the translation and the efficient protein synthesis of its targets. 
Consequently, we simultaneously discovered a new factor contributing to translation at the ER and 
moreover formulate the hypothesis that HDLBP influences the SRP-mediated translation arrest. 
Furthermore, we showed that modulation of ER-associated translation (by HDLBP KO in A549 cells) 
can dramatically impact tumor formation in nude mice highlighting the broader biological 
significance of HDLBP.    
 
In the following sections these findings will be discussed in more detail. First the binding 
characteristics of HDLBP to its mRNA targets will be addressed, next functions of HDLBP will be 
covered and subsequently the effect of HDLBP on tumor formation will be debated. Finally, we will 
speculate about how HDLBP achieves its function and will discuss mechanistic details.  
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HDLBP binding to mRNAs 
To understand the RNA binding characteristics of the human HDLBP, we determined transcriptome-
wide HDLBP binding sites using PAR-CLIP in HEK293 cells. We found that HDLBP mainly binds to the 
CDS of mRNAs that encode membrane and secretory proteins (Figure 5). Since it is known that these 
mRNAs are targeted to the ER, we investigated to which extent HDLBP binds ER-localized mRNAs. 
Therefore, we carried out cell fractionation experiments coupled to RNA-sequencing and defined 
cytosol and ER-localized mRNAs in HEK293 cells. Overlapping our PAR-CLIP identified HDLBP 
targets with ER-localized mRNAs allowed us to estimate that HDLBP binds more than 80% of all ER-
localized mRNAs (Figure 9). Analysis of the binding motif showed that HDLBP predominantly binds 
to a CU-containing motif and forms high affinity multivalent interactions primarily in the CDS of ER-
localized mRNAs (Figure 14, Figure 17). Therefore, ER-localized mRNAs differ from cytosol-localized 
mRNAs in regard to their frequency of HDLBP binding sites. These findings extent our understanding 
of HDLBP mRNA binding selectivity.  
 
HDLBP binding motif 
Previously, PAR-CLIP experiments using primary hepatocytes showed that the mouse homolog of 
HDLBP binds a CHHC or CHYC (H = A/C/U and Y = C/U) motif that is separated by 2, 5 or 8 nt (Mobin 
et al., 2016). Furthermore, in vitro assays identified that human HDLBP and its xenopus homolog bind 
to (A)nCU and CU(A)n within a 75 nt long single stranded region (Kanamori et al., 1998). As a 
conclusion from these studies, it was suggested that HDLBP binding sites lack sequence specificity 
(Cheng and Jansen, 2017).  
We demonstrated that HDLBP forms multivalent interactions and identified a ~40 nt long HDLBP 
binding site consisting of interspaced 3-4 UC/CU containing 4-mers (Figure 17). Likely, the KH 
domain array of HDLBP (Figure VIII) is mediating these multivalent interactions. The identified 
HDLBP binding site suggests that 3-4 KH domains recognize the 3-4 UC/CU containing 4-mers. 
However, it is not known if specific HDLBP KH domains recognize this motif or whether every HDLBP 
KH domain (or at least every classical KH domain) is able to bind to it. A proteome-wide screen 
carried out in HEK293 cells identified protein sequence regions, including HDLBP regions, that 
interact with mRNAs (Mullari et al., 2017). This screen is based on UV crosslinking and digestion of 
RNA-bound proteins followed by mass spectrometry. Thereby, HDLBP peptides corresponding to the 
KH domains 2, 3, 5 and 11 were recovered indicating that they contact RNA. Surprisingly, also the 
divergent KH domain 2 was found to bind RNA. However, further work is needed to decipher the 
impact and contribution of each KH domain to the HDLBP RNA substrate specificity. Interestingly, it 
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was reported for other KH-domain containing proteins like the IGF2BP protein family that they may 
recognize bipartite motifs (Biswas et al., 2019; Dagil et al., 2019). IGF2BP contains 4 KH domains and 
structural studies suggested that KH domain 3 recognizes ß-actin 5´-(C/A)CA(C/U)-3´ sequences, 
whereas KH domain 4 binds to ß-actin 5´-CGGAC-3´ sequences (Biswas et al., 2019). This highlights 
that KH domains can have different specificities and that future studies are necessary to fully 
understand the interplay of the 15 HDLBP KH domains.   
 
Conservation of HDLBP binding specificity 
The core of our identified HDLBP binding motif consists of UC/CU containing 4-mers. This is in 
agreement with the above mentioned reports and suggests that the binding motif of HDLBP might, 
to some extent, be conserved from frog and mouse to human. Moreover, also the mRNA targets of 
HDLBP could be conserved because the mouse homolog was shown to bind to mRNAs encoding 
secretory proteins (Mobin et al., 2016). However, this study suggested that HDLBP only binds to 
17,5% of all mRNAs encoding secretory proteins, pointing into the direction that HDLBP has a 
specialized role in liver metabolism and secretory tissues. Since this statement is based on PAR-CLIP 
experiments using primary mouse hepatocytes, a possible explanation for this finding might be that 
the primary tissue limited the resolution of the experiment. In contrast, our cell culture system 
allowed us to use sufficient input material to obtain a very deep data set. Thereby, we identified that 
HDLBP is not specifically binding a small subset of mRNAs. Instead, HDLBP binds to more than 80% 
of all ER-localized mRNAs rather pointing to a general function for HDLBP in ER translation which 
could explain why HDLBP is ubiquitously expressed. 
 
HDLBP binding motif represents a common sequence feature of ER-localized mRNAs 
Furthermore, we show, in contrast to previous studies, that HDLBP mainly binds to the CDS of ER-
localized mRNAs, whereas mRNAs localized in the cytosol show less HDLBP binding sites randomly 
distributed between the CDS and 3’UTRs (Figure 11, Figure 12). Thereby, we identified the HDLBP 
binding site as a common sequence feature within the CDS of ER-localized mRNAs. In doing so, we 
advanced the understanding of regulatory elements within ER-localized mRNAs and simultaneously 
described for the first time an RNA-binding protein that specifically binds to this regulatory cis-
element.   
Interestingly, the identified sequence feature of ER-localized mRNAs seems to overlap with the 
recently described SECReTE motif which consists of up to 10 nucleotide triplet repeats enriched with 
C and U every third base (Cohen-Zontag et al., 2019). Moreover, Cohen-Zontag et al. examined which 
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RNA-binding proteins can potentially bind the SECReTE motif in yeast. To this end, they investigated 
how many mRNA targets of a specific RNA-binding protein contain the SECReTE motif and found that 
~70% of the previously identified Scp160p mRNA targets do so suggesting that the yeast homolog of 
HDLBP has the potential to interact with the SECReTE motif (Cohen-Zontag et al., 2019). However, 
no experimental evidence was provided showing that Scp160p recognizes the SECReTE motif. Cohen-
Zontag and coworkers also noted that, contrary to yeast, the SECReTE motif in human transcripts 
preferentially occurs in UTRs especially in 3’UTRs. In contrast, our described HDLBP binding site is 
primarily detected in the CDS. Further analysis is needed to understand to which extent the SECReTE 




To determine the function of HDLBP in human cells, we pursued two hypotheses. Based on previous 
research, we hypothesized that HDLBP is either involved in translation regulation or in directing its 
targets to the ER.  
 
Impact of HDLBP on mRNA transport to the ER 
To test whether HDLBP has an effect on mRNA transport to the ER, we carried out cell fractionation 
experiments and separated the membrane fraction containing ER-localized mRNAs from the cytosol 
fraction. Subsequently, we sequenced the RNA of both fractions in HEK293 HDLBP KO and parental 
(WT) cells. Comparing the results between WT and HDLBP KO cells, we found no significant changes 
suggesting that HDLBP is not involved in mRNA localization in human cells (Figure 22). However, our 
global experimental approach is based on the biochemical separation of the cytosol and membrane 
compartment and we cannot rule out that HDLBP influences mRNA localization on a more subtle 
level that would not be detected with our setup. To further validate our findings and to analyze mRNA 
localization in more detail, one could carry out fluorescent in situ hybridization (FISH) experiments 
and visualize the cellular distribution of a specific HDLBP mRNA target. That would allow a high 
resolution, but would have the disadvantage that only limited HDLBP mRNA targets could be tested. 
A good candidate for FISH experiments would be the ER chaperone BiP, because we noticed for this 
HDLBP target less enrichment in the membrane fraction upon HDLBP KO. We tested if this is 
biological meaningful and carried out electron microscopy imaging and compared the ER 
morphology of WT and HDLBP KO cells because it was previously shown that BiP mis-regulation 
could lead to ER morphology defects (Li et al., 2008). However, there were no detectable ER 
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morphology differences between WT and HDLBP KO cells suggesting that BiP is not impaired to a 
level that would affect ER morphology (Figure 23).  
 
Impact of HDLBP on translation 
To test if HDLBP has an effect on translation, we carried out ribosome profiling in HEK293 WT and 
HEK293 HDLBP KO cells. We found that ER-localized mRNA targets of HDLBP showed less translation 
efficiency upon HDLBP KO suggesting that HDLBP indeed influences translation (Figure 25). To 
validate this finding, we performed pSILAC experiments and detected the corresponding decrease in 
protein synthesis of proteins encoded by mRNAs that are bound by HDLBP and ER-localized (Figure 
27).  
 
Our findings are in agreement with previous studies carried out in yeast (Baum et al., 2004; Frey et 
al., 2001; Hirschmann et al., 2014; Li et al., 2004; Weber et al., 1997) and mice (Mobin et al., 2016) 
suggesting that HDLBP is involved in translation. More precisely, Mobin and colleagues suggested 
that HDLBP enhances the translation of a subset of mRNAs encoding secretory proteins. This is based 
on their observation that several proteins showed decreased secretion from mouse primary 
hepatocytes upon HDLBP knockdown. However, direct evidence for the function of HDLBP as a 
translation enhancer was only provided for one HDLBP target by in vitro translation assays. In 
contrast to this and other studies, we show for the first time on a global scale in human cells that 
HDLBP influences translation and determined which mRNAs are less translated in absence of HDLBP.  
 
To further understand how exactly HDLBP is influencing translation, we analyzed our ribosome 
profiling and PAR-CLIP data in more detail and made several observations.  
Interestingly, we detected less ribosome profiling reads after the exposure of the signal peptide or 
the first transmembrane domain upon HDLBP KO (Figure 25). Thereby, we show for the first time 
that KO of a specific protein affects the read density in that region. According to the SRP hypothesis, 
one would expect that exposure of the targeting signal would cause a translation arrest and assuming 
that this is the case, less reads in this region can be interpreted as a reduced translation arrest caused 
by HDLBP KO. However, the existence of the translation arrest in vivo is debated in the field because 
it was expected that it would be detectable as a distinct peak in ribosome profiling data which was 
not observed in previous (Chartron et al., 2016; Schibich et al., 2016) and in our results. As explained 
in detail in the introduction (see “The signal recognition particle (SRP)” -> “More recent findings”) 
this expectation has several flaws and it is unclear at which time point exactly the translation arrest 
occurs and which read pattern it causes in ribosome profiling data. Therefore, we assume that the 
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translation arrest occurs at multiple positions along the mRNA (not causing a distinct peak) and 
argue that HDLBP is involved in mediating this translation arrest because we detect upon HDLBP KO 
significantly less reads especially in the region after exposure of the targeting signal. However, this 
conclusion needs further experimental validation. Therefore, it is crucial to understand on the one 
hand the mechanistic interaction between HDLBP and the SRP. Speculations about this interaction 
will be covered below (see “Unresolved questions and outlook”). On the other hand further studies 
are needed to clarify the specifics of the translation arrest in vivo because in vitro experiments clearly 
suggest that the SRP causes a translation arrest (Figure V).  
 
Moreover, our ribosome profiling data revealed that HDLBP KO leads to higher ribosomal occupancy 
for various codons. We analyzed our PAR-CLIP data to understand if these codons (e.g. CUU, UUC) 
are also bound by HDLBP and found that this is indeed the case. Additionally, these codons are also 
decoded by tRNAs that are bound by HDLBP. Previously, it was shown that depletion of the yeast 
homolog of HDLBP decreases the relative abundance of ribosome-associated tRNAs (Hirschmann et 
al., 2014). To show this, Hirschmann et al. developed a protocol to detect tRNAs that co-precipitated 
with the ribosome and quantified the tRNA levels by real-time PCR in WT yeast and upon Scp160p 
depletion. As a conclusion, the authors suggested that Scp160p either increases the efficiency of tRNA 
recharge, or that Scp160p prevents the diffusion of discharged tRNAs. Our study supports these 
conclusions, but further experiments are needed to decipher the mechanistic and functional 
consequences of HDLBP binding to tRNAs. Nevertheless, we provide for the first time a detailed 
analysis of HDLBP binding to tRNAs. We determined which tRNAs are most prominently bound by 
HDLBP and detected that HDLBP tRNA crosslinking sites commonly occur in the variable and D loops. 
In addition, we found that several codons decoded by HDLBP bound tRNAs show higher ribosomal 
occupancy upon HDLBP KO.  
 
Impact of HDLBP on protein secretion and cell surface expression  
To monitor the impact of HDLBP on secretion in human cells, we intended to compare the secretomes 
of HEK293 WT and HDLBP KO cells. However, our global mass spectrometry based assessment 
resulted in non-quantifiable results presumably because our secretomes were contaminated by 
cellular proteins likely because HEK293 cells easily detach from culture plates. As a consequence, we 
used standard reporter assays and compared the secretion of two reporters from WT and HDLBP KO 
cells. Analyzing the mRNA sequences of Gaussia luciferase and SEAP, we identified several potential 
HDLBP binding sites and therefore it is very likely that HDLBP binds to mRNAs encoding the reporter 
 
--   Discussion  --   63 
 
proteins. As a result, we found a reduction in Gaussia luciferase and SEAP secretion in HDLBP KO 
cells (Figure 33).  
To understand the downstream consequence of HDLBP binding to mRNAs encoding membrane 
proteins expressed in HEK293 cells, we chose to further study one HDLBP target TFRC/CD71. We 
detected several crosslinking sites of HDLBP to TFRC by PAR-CLIP and also validated HDLBP binding 
to TFRC mRNA by real-time PCR (Figure 6). Our ribosome profiling experiments showed that the 
translation efficiency of TFRC was reduced and also pSILAC experiments confirmed that less TFRC 
protein is synthesized in the membrane fraction in HDLBP KO cells (Figure 27). In addition, FACS 
experiments indicated a reduction of TFRC expression on the cell surface upon HDLBP KO (Figure 
34) providing evidence that HDLBP influences the surface expression of proteins encoded by mRNAs 
that are bound by HDLBP.  
Overall, that suggests that HDLBP promotes the translation of its ER-localized mRNA targets which 
has functional consequences because also the protein synthesis, the secretion or surface expression 
are affected downstream. 
 
 
HDLBP effect on tumor initiation and formation  
Since HDLBP influences the secretion and surface expression of proteins encoded by mRNAs that are 
bound by HDLBP, we wanted to further determine the biological relevance of HDLBP. To this end, we 
used the lung carcinoma cell line A549 and first analyzed the viability and growth behavior of A549 
HDLBP KO cells in comparison to parental A549 cells. Interestingly, HDLBP KO cells were less viable 
and grew slower. This encouraged us to investigate the effect of HDLBP on lung tumor initiation and 
formation in vivo. Strikingly, HDLBP KO cells only formed tumors in 3 out of 8 nude mice, whereas 
WT cells formed as expected tumors in all 8 mice. The remaining 3 tumors initiated by HDLBP KO 
cells showed a reduced tumor volume and weight suggesting that HDLBP is involved in lung tumor 
formation and progression. Therefore, HDLBP might be a promising therapeutic target to inhibit lung 
tumor growth and additional studies are needed to further explore the therapeutic potential of 
HDLBP and its impact on tumor biology in general.  
 
These results are in agreement with results obtained from human hepatocellular carcinoma cells 
where HDLBP was shown to be required for cell proliferation and tumor growth (Yang et al., 2014). 
However, other studies suggest that HDLBP may function as a tumor repressor in breast cancer cell 
lines (Woo et al., 2011) and human sarcoma cells (Molyneux et al., 2014). In consequence of these 
contradictory findings, we expect that the phenotype caused by mis-regulation of HDLBP is cell type 
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dependent. In support of this, several disease phenotypes have been reported to be influenced by 
HDLBP as elaborated in the introduction (see “Disease relevance”).  
 
Nevertheless, we speculate that most prominent phenotypes caused by dysfunctional HDLBP occur 
when ER translation is particularly critical. This is the case for example for specialized secretory cells 
in which HDLBP also shows the highest expression (Figure VII).  
Furthermore, ER translation is crucial for the replication of several viruses and HDLBP KO resulted 
in less virus load of dengue and Zika viruses which are known to replicate in close association to the 
ER (Ooi et al., 2019). In contrast, the virus load of HDLBP KO cells was not altered after infection with 
a virus that replicates in the cytosol (Chikungunya virus) (Ooi et al., 2019; Silva and Dermody, 2017). 
In addition, Ooi et al. also performed infrared crosslinking and immunoprecipitation (irCLIP) of 
HDLBP on uninfected and virus-infected cells (dengue and Zika viruses). They found that HDLBP 
binds in uninfected cells mainly to mRNAs and upon virus infection more than 50% of all reads 
mapped to viral RNA (Ooi et al., 2019). This further illustrates the potential importance of HDLBP for 
virus biology and additional studies are needed to assess how this can be exploited.  
 
Furthermore, HDLBP might influence protein folding and protein aggregation. Previously, loss of the 
HDLBP yeast homolog was shown to influence the aggregation of many Q/N-rich proteins and to 
reduce aggregation of polyQ reporters used in this study (Cheng et al., 2018). Cheng et al. speculated 
that this is because Scp160p slowed down the translation of the polyQ reporters. Furthermore, it was 
reported that modulations of the translation rate affect protein folding (Rodnina, 2016; Waudby et 
al., 2019) and mis-folding can cause potentially toxic protein aggregation. Here, we found that human 
HDLBP influences the translation efficiency of its targets and we also detected global stalling upon 
HDLBP KO. Therefore, we speculate that HDLBP could impact protein folding and in support of this 
we found key chaperones and chaperonins in close proximity to HDLBP. However, the influence of 
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Unresolved questions and outlook 
Possible mechanisms of how HDLBP functions in translation  
HDLBP is a cytoplasmic protein in HEK293 cells that co-localizes with the ER where it influences the 
translation of its mRNA targets. These mRNA targets are mainly bound by HDLBP in their CDS. 
Moreover, our data also provide evidence that HDLBP binds to tRNAs, ribosomes, the SRP and is 
primarily in close proximity to proteins associated with translation. How do these interactions 
connect up to create a conclusive hypothesis on how HDLBP functions in translational control?  
 
After the transcription of an mRNA, the mRNA is processed and exported from the nucleus into the 
cytosol. Here, the translation initiates and the ribosome-nascent-chain complex either first moves to 
the ER or directly continues the translation in the cytosol. Due to the cellular localization of HDLBP 
and the fact that it prefers to bind to the CDS, the time window in which HDLBP influences its mRNA 
targets is rather short. On one hand, it can only happen after the mRNA is exported from the nucleus 
because we detect HDLBP only in the cytoplasm. On the other hand, HDLBP binding to the CDS of its 
targets is most likely interrupted once the ribosome starts translating the mRNA. Therefore, we 
hypothesize that HDLBP is predominantly important for the pioneer round of translation after which 
it is removed.  
 
Crucial for the pioneer round of translation is that, upon nuclear export, several complexes are still 
bound to the mRNA (Maquat et al., 2010; Woodward et al., 2017). This includes the exon junction 
complex, which for example, ensures proper functionality of each mRNA because nonfunctional 
mRNAs will be identified and subsequently eliminated. Moreover, exported mRNAs are bound by the 
nuclear cap-binding protein heterodimer CBP80-CBP20. This complex is needed for the loading of 
ribosomes on the mRNA and is afterwards replaced by eIF4E (Maquat et al., 2010). We do not find 
evidence that HDLBP is involved in these first steps of the pioneer round of translation because no 
important factors like the exon junction complex are in close proximity to HDLBP as determined by 
our BioID experiment. However, several translation initiation factors including eIF4E are in our BioID 
data set suggesting that HDLBP gets involved once eIF4E directs translation initiation. Next, the 
majority of mRNAs bound by HDLBP are targeted to the ER where the final protein is synthesized. 
Therefore, it is likely that HDLBP functions between translation initiation, ER-targeting and the first 
round of translation. This also suggests that HDLBP modulates active translation. In a proteome-wide 
screen in MCF7 cells, HDLBP was identified to show significantly decreased RNA-binding upon 
arsenite-induced global translation arrest which supports this notion (Trendel et al., 2019). However, 
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we only have limited data to further speculate about mechanistic details about the role of HDLBP in 
translation and several scenarios are conceivable.  
 
Is HDLBP influencing translation initiation and/or elongation? 
It could be possible that HDLBP directly influences translation initiation and/or elongation. Data 
supporting this are mainly our ribosome profiling identified global stalling observations upon HDLBP 
KO. We detected higher read coverage at P sites but most prominently at E sites. This could be an 
argument that HDLBP is influencing translation elongation, because it was suggested that the E site 
functions as a sensor of ribosome elongation kinetics (Schuller and Green, 2018). Therefore, global 
stalling mostly at E sites upon HDLBP KO might be consequence of a modified translation elongation 
rate during the pioneer round of translation. Moreover, a role of HDLBP in translation elongation 
would be in agreement with its mRNA binding preference (all over the CDS). However, we only 
detected HDLBP in close proximity to 2 translation elongation factors (eEF1B2, eEF1D). In contrast, 
we found 11 different translation initiation factors in close proximity to HDLBP. Therefore, HDLBP 
could also enhance translation initiation by simultaneously binding to its mRNA targets and to 
ribosomes leading to a higher ribosome load on HDLBP mRNA targets. Further experiments are 
needed to decipher how HDLBP influences translation initiation and/or elongation.  
 
Is HDLBP influencing the SRP cycle? 
Furthermore, it could be possible that HDLBP influences the ER-targeting step and thereby promotes 
the translation of its ER-localized targets. Most mRNAs are targeted to the ER by the SRP. However, 
also mRNAs with no known targeting signal are localized to the ER probably in a SRP-independent 
manner. Interestingly, HDLBP contributes to efficient translation of both SRP-dependent and –
independent mRNAs. Since it is not known how exactly SRP-independent mRNAs are targeted to the 
ER it is hard to speculate how HDLBP contributes to their efficient translation. In contrast, 
speculations about the contribution of HDLBP to the SRP cycle are more profound. From structural 
considerations, it would be conceivable that HDLBP stabilizes the SRP-ribosome-mRNA interaction 
and thereby also contributes to translation arrest. Data that support this hypothesis are mainly our 
PAR-CLIP identified HDLBP crosslinking sites detected in the 7SL RNA and the 40S ribosomal subunit 
which are in proximity to translation initiation and elongation factor binding sites. Therefore, HDLBP 
binding to these sites could influence the translation arrest. Besides these structural considerations, 
we also found reduced ribosomal occupancy around targeting signals upon HDLBP KO moreover 
suggesting that HDLBP influences translation arrest. However, this hypothesis would not explain 
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why HDLBP binds its ER-localized mRNA targets all over the CDS and not predominantly around the 
first targeting signal. In addition, one would expect that a non HDLBP stabilized SRP-ribosome 
interaction would not only impair efficient translation, but furthermore would result in less efficient 
ER-targeting of the complex which is not supported by our data.  
 
To further decipher the contribution of HDLBP to the SRP cycle it is fundamental do understand when 
exactly HDLBP affects its mRNA targets in relation to the SRP. Does it affect its targets during 
translation initiation before the SRP is recruited? Could HDLBP be a “marker” for ER-destined mRNAs 
and could thereby help the SRP to bind to the correct ribosome-nascent-chain complexes? Is the 
HDLBP-SRP interaction crucial for the function of HDLBP or does HDLBP influence its targets after 
the SRP dissociates by modulating the translation elongation rate?  
First step, in order to answer these questions, would be to determine ribosome-nascent chain 
complexes that are bound by the SRP in a human system. Since selective ribosome profiling of SRP-
bound ribosomes was already successfully performed in yeast (Chartron et al., 2016) it would be 
insightful to establish this experiment in human cells. Next, the same experiments could be carried 
out using HDLBP KO cells. Comparing both data sets would help to identify if HDLBP KO results in a 
different SRP binding pattern which would help to further characterize the HDLBP-SRP interaction.  
 
Overall, we demonstrate that the highly conserved and ubiquitously expressed protein HDLBP has a 
general function in the translation of ER-localized mRNAs and future research will clarify the 
mechanistic details and exploit the therapeutic potential of HDLBP.   
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MATERIALS AND METHODS 
Related to results chapter [1] 
Cell lines and culture conditions 
HEK293 Flp-In T-Rex cells (HEK293) (Thermo Fisher Scientific), HEK293 stable cell lines, HDLBP KO 
cell lines, A549 cells and A549 HDLBP KO cell lines were grown in standard Dulbeco´s modified 
Eagle´s medium (DMEM) (Thermo Fisher Scientific) supplemented with 10% fetal bovine serum 
(Sigma-Aldrich) and 1% L-glutamine (200 mM, Thermo Fisher Scientific).  
Stable HEK293 cell lines expressing BirA-FLAG-HDLBP or FLAG/HA-HDLBP were generated by 
hygromycin selection (Gregersen et al., 2014). Induction of the stable cell lines was achieved by 
adding 1 μg/ml of doxycycline (DOX) to the culture medium for ~16 h. 
HEK293 and A549 HDLBP knockout cell lines were generated using the Edit-R CRISPR-Cas9 Gene 
Engineering kit (Dharmacon) according to manufacturer´s protocol. Briefly, transfections of 
synthetic tracr RNA (U-002000-05), hCMV-PuroR-Cas9 (U-005100-120) and predesigned HDLBP 
crRNA (either guide 1 (CR-019956-01-0005, target sequence: TGCTCCTCCTGCAGATTAAC) or guide 
2 (CR-019956-04-0005, target sequence: GAGCGACCCTCCAACCTACA)) were performed using 
DharmaFECT Duo transfection reagent (T2010-01) in a 12-well plate. Cells were transferred after 2 
days to a 10 cm dish and treated with puromycin (2 μg/ml for HEK293 cells and 1 μg/ml for A459 
cells). The surviving colonies were selected and analyzed by Western Blot.  
 
Western Blot 
Cell pellets were resuspended directly in Laemmli buffer, sonicated (5-second-pulse at 80% 
amplitude) and centrifuged (10000 g, 10 min, 4°C). Before resolving the proteins by SDS-PAGE the 
samples were boiled for 3 min (95°C). To transfer the proteins to a nitrocellulose membrane 
(Whatman) a semi-dry blotting apparatus (20 V for 1 h) was used. The membranes were blocked 
with 5% non-fat milk for 1 h and subsequently incubated with the primary antibody overnight. After 
washing the membranes 3 times with TBST (150 mM NaCl, 20 mM Tris-HCl [pH 7.5], 0,1% Tween20) 
for 5 min the membranes were incubated with horseradish peroxidase conjugated secondary 
antibody for 2 h. The membranes were washed 3 times with TBST for 5 min, bands were visualized 
with an ECL detection reagent (GE Healthcare) and imaged with a LAS-4000 imaging system or an 
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Related to results chapter [2] 
Immunohistochemistry 
HEK293 cells were grown on coverslips in 6-well plates. ER-Tracker Red (Thermo Fisher Scientific) 
was used according to manufacturer´s instructions. The medium was removed and cells were washed 
with PBS. Cells were fixed with 3,7% formaldehyde in PBS for 10 min at room temperature. After 
washing the cells twice with PBS, cells were permeabilized with 0,2% Triton X-100 in PBS for 10 min 
at room temperature. Cells were washed twice with 0,05% Tween20 in PBS (PBST) and blocked with 
10% FBS in PBST for 30 min at room temperature. The primary antibody (HDLBP) was diluted 1:500 
in PBST and incubated over night at 4°C. After washing twice with PBST, the secondary antibody was 
applied (Alexa Fluor 488 anti-rabbit, 1:2000 in PBST) for 1 h at room temperature. Cells were washed 
5 times with PBST. Hoechst staining (1:2000 in PBST, stock concentration: 1mg/ml) was carried out 
for 15 min at room temperature. After washing twice with PBS, cover slips were mounted with 
ProLong Gold Antifade Mountant (Thermo Fisher Scientific) and imaged with a Keyence microscope 
(BZ-X700).  
     
Related to results chapter [2-6] 
Cell fractionation 
Cell fractionation by sequential detergent extraction was carried out as previously described 
(Jagannathan et al., 2011) with minor modifications. HEK293 and HEK293 HDLBP knockout cell lines 
(1 dish (15 cm) per replicate) were grown to ~90% confluency and washed with PBS. All further 
steps were performed on ice using ice cold reagents and cells were always pelleted at 3000 g for 5 
min at 4°C. First, PBS containing 50 μg/ml cycloheximide was added for 10 min and in the meantime 
cells were scraped. After pelleting, the cells were resuspended with 500 μl permeabilization buffer 
(110 mM KOAc, 25 mM K-HEPES [pH 7. 2], 2.5 mM Mg(OAc)2, 1 mM EGTA, 0,015% digitonin, 1 mM 
DTT, 50 μg/ml cycloheximide, complete EDTA-free protease inhibitor cocktail [Roche], 40 U/mL 
SUPERaseIn (Thermo Fisher Scientific)) per sample. After 15 min of incubation at 4°C on a rotating 
wheel, the cells were pelleted. The supernatant was collected as the cytosolic fraction. The pellet was 
washed with 5 ml of washing buffer (110 mM KOAc, 25 mM K-HEPES [pH 7.2], 2.5 mM Mg(OAc)2, 
1mM EGTA, 0,004% digitonin, 1 mM DTT, 50 μg/ml cycloheximide). After pelleting, cells were 
resuspended with 500 μl lysis buffer (400 mM KOAc, 25 mM K-HEPES [pH 7.2], 15 mM Mg(OAc)2, 
0,5% IGEPAL CA-630, 1 mM DTT, 50 μg/ml cycloheximide, complete EDTA-free protease inhibitor 
cocktail, 40 U/mL SUPERaseIn) per sample. After 5 min of incubation, cells were pelleted and the 
supernatant was collected as the membrane fraction. Next, fractions were clarified by centrifugation 
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at 7500 g for 10 min at 4°C. 250 μl of each sample was collected and subsequently the RNA was 
isolated using Trizol LS (Thermo Fisher Scientific) in combination with RNA Clean & Concentrator-
25 kit (Zymo Research) for RNA-sequencing (see “RNA-sequencing library preparation”).  
 
RNA-sequencing and data analysis  
The TruSeq Stranded mRNA kit (Ilumina) was used according to manufacturer´s protocol with 1 μg 
of RNA as input for preparation of RNA sequencing libraries. Next generation sequencing runs were 
performed on a HiSeq 4000 or NextSeq 500 Illumina instruments. After demultiplexing the reads, the 
3’adapter sequences were removed by Flexbar (v2.5). Read counts per gene and TPM values were 
calculated by RSEM (v.1.2.20) (Li and Dewey, 2011) using default parameters and Bowtie (v.1.1.2) 
(Langmead et al., 2009) as transcriptome alignment program. For normalization raw read counts and 
pairwise comparisons between and within fractions DESeq2 (Love et al., 2014) was used with 
standard parameters. The DESeq2 output provided log2-transformed fold changes. Membrane-to-
cytosol enrichment was equivalent to the log2-transformed fold change between membrane and 
cytosolic samples. To classify membrane-localized and cytosolic mRNAs, we used cutoffs of >=1.5 and 
<=0.5, respectively, for all mRNAs with TPM>=10.  
 
Targeting signal annotations  
Signal peptide and transmembrane helix annotations were obtained from Ensembl Biomart 
(http://grch37.ensembl.org/biomart/martview), which uses SignalP (Bendtsen et al., 2004) and 
TMHMM (Krogh et al., 2001) for annotation. Annotations were downloaded in protein sequence 
coordinates which were converted into transcript coordinates by Biostrings (v2.52.0, Bioconductor). 
Based on these annotations, we classified tail-anchored proteins as those proteins lacking signal 
peptide, for which the first transmembrane helix started 50 or less amino acids from the C-terminus. 
We classified mitochondrial DNA encoded proteins as those that contained an “MT-“ prefix in their 
gene symbol. A list of mitochondrial proteins encoded in the nuclear DNA was downloaded from 
Mitocarta (Calvo et al., 2016). 
 
PAR-CLIP and data analysis  
Experimental conditions 
PAR-CLIP was carried out as described previously (Hafner et al., 2010) with minor modifications. 
Stable cell lines expressing FLAG/HA-HDLBP were grown with 100 μM 4sU for 16 h (20 dishes (15 
cm) per replicate). Cells were UV crosslinked (365 nm, 0.15 J/cm²), harvested, snap frozen and 
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subsequently stored at -80°C. Cell pellets were incubated for 30 min on ice with 3 cell pellet volumes 
of lysis buffer (50 mM Tris-HCl [pH 7.4], 100 mM NaCl, 1% IGEPAL CA-630, 0,1% SDS, 0,5% sodium 
deoxycholate, complete EDTA-free protease inhibitor cocktail [Roche]). Cell lysates were cleared 
(13000 rpm, 15 min, 4°C) and filtered. RNase T1 was added at final concentration of 1 U/μl for 10 
min at 22°C. 20 μl beads (Dynabeads Protein G, Thermo Fisher Scientific) per 1 ml lysis buffer were 
washed twice with lysis buffer and incubated for 1 h with 0,25 μg/μl FLAG antibody (Sigma-Aldrich, 
F1804). Afterwards beads were washed twice with lysis buffer and added to the sample. After 2 h 
incubation at 4°C on a rotating wheel the beads were washed with IP wash buffer (50 mM HEPES-
KOH [pH 7.5], 300 mM KCl, 0,05% IGEPAL CA-630, 0,5 mM DTT, complete EDTA-free protease 
inhibitor cocktail) 3 times. A second RNase T1 treatment was carried out and for replicate 1, a final 
concentration of 1 U/μl and for replicate 2 a final concentration of 15 U/μl was used for 10 min at 
22°C. Subsequently, beads were washed with high-salt wash buffer (50 mM Tris-HCl [pH 7.4], 1 M 
NaCl, 1% IGEPAL CA-630, 0,1% SDS, 0,5% sodium deoxycholate, 1 mM EDTA, complete EDTA-free 
protease inhibitor cocktail [Roche]) 3 times. Afterwards beads were washed 2 times with 
polynucleotide kinase buffer (50 mM Tris-HCl [pH 7.5], 50 mM NaCl, 10 mM MgCl2, 5 mM DTT). Next, 
samples were radiolabeled using T4 polynucleotide kinase (NEB) and resolved on a Novex 4-12% 
BisTris gel (Thermo Fischer Scientific). The HDLBP-RNA complexes were transferred to a 
nitrocellulose membrane (Whatman), exposed for 30 min to a phosphorimager screen and excised 
at approximately 160 kDa. After proteinase K (Roche, 40 min at 50°C) digestion the RNA was purified 
by phenol-chloroform treatment and precipitation. For preparation of sequencing libraries the RNA 
was firstly ligated to a 3’ adapter 4N-RA3 (see “Oligonucleotides”) and gel-purified using a 15% 
denaturing urea-PAGE gel (Carl Roth). Next, the 5’ adapter OR5-4N (see “Oligonucleotides”) was 
ligated and gel purified using a 17% denaturing urea-PAGE gel. The RNA was reverse transcribed and 
PCR-amplified using Phusion High-Fidelity DNA polymerase (Thermo Fischer Scientific) (see 
“Oligonucleotides”). The cDNA was visualized on a 2,5% agarose gel and a 140-160 bp sized fragment 
was excised which was purified using the Zymoclean Gel DNA Recovery kit (Zymo Research). Next 
generation sequencing was performed on a HiSeq 2500 Illumina instrument (1x51+7 cycle). 
Data analysis  
Reads were demultiplexed and the 3’adapter sequence was removed by Flexbar (v2.5). Next, reads 
were collapsed to remove PCR duplicates. This was followed by trimming of 4 nucleotides from both 
5’ and 3’ end of the read by FASTX Toolkit v0.0.14. The reads were aligned to the human genome 
(hg19 build) using BWA v0.7.15-r1140 and the computational PAR-CLIP pipeline (v0.97a) 
(https://github.com/marvin-jens/clip_analysis) (Lebedeva et al., 2011). Briefly, read clusters were 
called from unique alignments and scored for characteristic T-to-C conversions. After false positive 
 
--   Materials and methods  --   72 
 
filtering (using antisense clusters as a decoy database and a false discovery rate of 0.05) the 
remaining clusters were kept and written as bed files. In addition, clusters obtained from each 
biological replicate were filtered for reproducibility and only those clusters were considered that 
overlapped by at least 50% of their nucleotide length between replicates. Furthermore, we required 
that the positions of the highest T-to-C conversion values per cluster were no more than 10 nt apart 
between 2 replicates. Each kept cluster was also required to have at least 3 or more mean T-to-C 
conversions calculated between replicates. To obtain gene level binding information, we summed T-
to-C conversions in reproducible clusters for each gene. Thereby, we obtained the total number of 
crosslink positions within whole mRNAs, or within the CDS, 5’UTR or 3’UTR. To correct for PAR-CLIP 
expression level bias, we divided total number of crosslinks per gene by the corresponding TPM value 
which was obtained by RSEM (v.1.2.2) from our RNA-sequencing experiment from total HEK293 cells 
(see “RNA-sequencing and data analysis” description). As a result we obtained our PAR-CLIP 
enrichment values.  
To assess the relative distribution of T-to-C conversions within the transcriptome and to obtain 
accurate mapping to transcripts originating from repetitive genomic loci, reads were sequentially 
mapped to reference transcripts by Bowtie2 (v2.3.2). This was done in the following order by 
retaining the unmapped reads from the previous to the next mapping step. First, mapping to human 
pre-rRNA (GenBank U13369.1) was carried out, followed by rRNA (GenBank NR_023363.1, 
NR_003285.2, NR_003287.2, NR_003286.2), snRNA, snoRNA, other ncRNA (all from Ensembl, 
including RN7SL), tRNA (GtRNADb), mtDNA (GenBank AF347015.1) and finally the human genome 
(hg19, iGenomes). The last genome-mapping step was carried out using the STAR aligner (v2.2.1) 
where only uniquely mapped reads (MAPQ=255) were retained. Except for the tRNA mapping (see 
“Mapping to reference tRNAs and quantification” description), we retained reads that mapped with 
a Bowtie2 MAPQ=20 or more and T-to-C conversions were extracted using 
row_mpile_coverage_plus_TC.pl script (Schueler et al., 2014). 
For transcriptome level analysis, the remaining reads (after mtDNA mapping) were aligned to the 
transcriptome sequence (GTF annotation file Gencode v19) using the STAR aligner (v2.2.1) by 
retaining only the reads that uniquely mapped to the hg19 genome (parameters --
outFilterMultimapNmax 1 --outFilterMismatchNmax 5 --outFilterMatchNmin 15 --
alignSJoverhangMin 5 --seedSearchStartLmax 20 --outSJfilterOverhangMin 30 8 8 8 --quantMode 
TranscriptomeSAM). For further analysis we considered only 1 transcript isoform per gene. This 
filtering was carried out based on RSEM (v1.2.2) results derived from our RNA-sequencing 
experiment from total HEK293 cells (see “RNA-sequencing and data analysis” description). Thereby, 
only the most highly expressed transcript isoform for a given gene was retained. T-to-C conversions 
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with transcriptome coordinates were obtained from the BAM file using the 
row_mpile_coverage_plus_TC.pl script (Schueler et al., 2014) and the output was written into a bed 
file. BedTools was used to intersect and to only keep reproducible T-to-C positions that were present 
in both replicates. Among those, we excluded T-to-C positions that were highly likely to be point 
mutations by retaining only those that had a transition specificity (positional T-to-C conversion count 
vs. total read coverage) lower than 0.95. To assess the positional HDLBP crosslinks across 5’UTR, CDS 
and 3’UTR, we used reproducible T-to-C conversions and normalized them for library size. Thereby, 
we obtained T-to-C conversions per million. Only transcripts with a total transcript T-to-C 
conversions per million of at least 5 in both replicates were included. For each T-to-C position we 
next derived the relative positions within 5’UTR, CDS or 3’UTR and divided the T-to-C per million 
value with the maximum T-to-C per million value of the corresponding transcript. For each position, 
we averaged the scaled T-to-C per million values over all transcripts and plotted them in regard to 
their nucleotide positions within 5’UTR, CDS or 3’UTR. Classification of membrane- and cytosol- 
localized mRNAs was carried out according to the results of our RNA-sequencing cell fractionation 
experiment.  
 
K-mer enrichment and multivalency analysis 
For these analyses, we made use of the reproducible T-to-C conversions per million values from the 
transcriptome level analysis as described in the PAR-CLIP data analysis section. To calculate the 
frequency of crosslinked k-mers (4-12 nt in length), we counted all possible k-mers at any 
crosslinking position for all membrane and cytosol-localized transcripts in their 5’UTRs, CDS and 
3’UTRs. The frequency was obtained by dividing with the total detected k-mer number in the whole 
sample. Next, k-mers were then ranked by their total frequency in the transcriptome. Top 10 k-mer 
frequencies were displayed according to mRNA localization and transcript region (5’UTR, CDS, 
3’UTR). 
For each transcript and its regions, we obtained k-mer specific crosslinking quantification by 
summing up the T-to-C conversion counts for each possible k-mer within a CDS and 3’UTR. In order 
to normalize this metric, we divided the values with the length of the respective CDS/3’UTR and with 
the transcript expression level as quantified by the total RNA-sequencing experiment (see “RNA-
sequencing and data analysis” description). Next, the k-mers were ranked according to the median 
of the log2-transformed normalized crosslinked k-mer signal.  
Sequence analyses of differentially localized transcripts and their regions were performed by 
calculating the k-mer frequency using the oligonucleotideFrequency function in Biostrings (v2.52.0, 
Bioconductor). We used fasta sequences of the same transcript subset as selected for PAR-CLIP and 
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ribosome profiling analyses. Thereby, we only retained the most highly expressed isoform per gene. 
For every k-mer length, we calculated the difference in frequency obtained from transcripts with 
differing localization and/or region (e.g. difference between cytosolic CDS and membrane CDS 
frequencies). Next, we computed the z-scores of the differences in frequency for the top 40 HDLBP 
crosslinked k-mers (as described above) and all other k-mers to compare between different k-mer 
lengths. Wilcoxon rank sum tests were used pairwise to compare z-score distributions between 
different k-mer lengths.  
To obtain multivalency scores for crosslinked 4-mers, we counted all crosslinked 4-mers in the 
region +40/-40 nt around each T-to-C conversion position by using the findOverlaps function of the 
Genomic Ranges package (v.1.36.0, Bioconductor) to obtain the nucleotide distances between all T-
to-C conversions within a transcript. The closest region (+4nt/-4nt) around the reference T-to-C 
conversion was excluded from counting, because it would otherwise dominate the total crosslink 
signal within the +40/-40 nt regions. Next, 4-mers were ranked by the frequency of detected 4-mers, 
which was obtained by dividing with the total number of all detected 4-mers within the +40/-40 nt 
regions excluding the closest region. For the top10 enriched 4-mers by frequency, we then binned 
the multivalency scores into 5 equally-sized categories and compared the total normalized T-to-C 
conversion signal over the +40/-40 nt regions. Next, we calculated the percentage of total T-to-C 
conversions for every nucleotide position within the +40/-40 nt region for each multivalency bin.  
Finally, we determined the multivalency potential of sequences of differentially localized transcripts 
and their regions. We chose two 4-mer groups, namely a positive set (UUCU), which consisted of top 
10 crosslinked 4-mers, and a negative set (AAGU). The negative set had a similar transcriptome 
frequency as the positive set but was not enriched in HDLBP PAR-CLIP. Next, we counted the 
occurrence of these 2 sets in 30-nt sliding windows in transcript sequences by using vcountPDict 
function in Biostrings. We kept all windows with at least three 4-mer group counts and summed them 
over transcript regions to obtain their frequency. Next, the distribution of the frequencies was 
compared between differentially localized transcripts and their regions with Wilcoxon rank sum 
tests. 
 
RNA co-immunoprecipitation and real-time PCR 
HEK293 stable cell lines expressing FLAG/HA-HDLBP were scraped, centrifuged in a capped syringe 
and frozen by pressing the cells through the syringe directly in liquid nitrogen. Frozen cells were 
grinded, aliquoted as powder and subsequently stored at -80°C. 200 mg cryopowder were 
resuspended with 1 ml of lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0,5% IGEPAL CA-630, 
complete EDTA-free protease inhibitor cocktail [Roche]) and incubated for 30 min on ice. In the 
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meantime samples were sonicated (5-second-pulse at 20% amplitude). Cell lysates were cleared 
(13000 rpm, 15 min, 4°C) and 25 μl beads (Dynabeads Protein G, Thermo Fisher Scientific) per 1 ml 
lysis buffer were washed twice with lysis buffer and coated for 1 h with 0,25 μg/μl FLAG antibody 
(Sigma-Aldrich, F1804) or with 0,25 μg/μl IgG antibody (Sigma-Aldrich, M5284). Next, beads were 
washed with lysis buffer twice and added to the sample. After 2 h incubation on a rotating wheel at 
4°C the beads were washed 5 times with lysis buffer and Laemmli buffer was added for Western Blot 
analysis or Trizol LS (Thermo Fisher Scientific) for RNA isolation. After RNA isolation a DNase (NEB, 
M0303) treatment and reverse transcription using SuperScript III Reverse Transcriptase (Thermo 
Fisher Scientific, 18080093) was performed according to manufacturer’s protocol. Real-time PCR 
was carried out using SYBR Green PCR Master Mix (Thermo Fisher Scientific, 4309155) and primers 
listed under “Oligonucleotides”. Finally, the fold enrichment was calculated from Ct values detected 
in anti-FLAG and IgG control samples (2^(anti-Flag CT value – IgG control CT value)).  
 
Related to results chapter [6] 
Mapping PAR-CLIP crosslinks to ribosome and SRP 3D structures 
For this analysis, we made use of our pre-rRNA and RN7SL alignments and extracted T-to-C 
conversions as described above in the PAR-CLIP section. Next, we aligned the pre-rRNA and RN7SL 
fasta files to the 18S rRNA and RN7SL fasta files which we obtained from the published structures 
(PDB id’s 4V6X, 6FEC, 3JAJ) (Anger et al., 2013; Eliseev et al., 2018; Voorhees and Hegde, 2015) and 
defined the orthologous position of the T-to-C conversion. We used Pymol (v.2.3.3) to simultaneously 
visualize translation initiation factors and expansion segments, as well as the SRP and expansion 
segments. Therefore, we juxtaposed 4V6X and 6FEC structures and in addition the 4V6X and 3JAJ 
structures using the align command. We labeled crosslinked nucleotides and other structural 
features accordingly.  
 
Additional published datasets 
IRE1 PAR-CLIP (Acosta-Alvear et al., 2018) was obtained by communication with the corresponding 
author and SSB PAR-CLIP datasets (Garzia et al., 2017; Gogakos et al., 2017) were obtained from GEO 
under accession GSE95683 and from SRA under accession SRR4301753. MOV10 PAR-CLIP 
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BioID and data analysis 
Experimental conditions 
The BioID proximity ligation assay was carried out as described before (Couzens et al., 2013) with 
minor modifications. HEK293 stable cell lines expressing BirA-FLAG-HDLBP (4 dishes (15 cm) per 
replicate) were incubated in the absence or presence of 1 μg/ml doxycycline for 24 h. Next, 250 μM 
biotin was added for 3.5 h. The cells were washed 4 times with PBS, harvested, snap frozen in liquid 
nitrogen and subsequently stored at -80°C. Cell pellets were incubated with 3 ml RIPA buffer (50 mM 
Tris-HCl [pH 7.5], 150 mM NaCl, 1% IGEPAL CA-630, 1 mM EDTA, 1 mM EGTA, 0,1% SDS, 0,5% 
sodium deoxycholate, complete EDTA-free protease inhibitor cocktail [Roche]) per sample for 10 min 
on ice. Next, the cell lysates were passed 8 times through a 21 G needle and sonicated (6 times 5-
second-pulses at 30% amplitude). 250 U benzonase (Merck Millipore) was added per sample for 1 h 
on ice at slow agitation. The cell lysates were cleared (15000 g, 15 min, 4°C) and filtered through a 5 
μm Supor membrane. To wash streptavidin sepharose (GE Healthcare, 17-5113-01), the suspension 
was centrifuged at 400 g for 1 min, the supernatant was removed and the sepharose was 
resuspended with 1 ml RIPA buffer (without 0,5% sodium deoxycholate and without complete EDTA-
free protease inhibitor cocktail). This wash step was repeated 2 times. Next, the RIPA buffer was 
removed and 40 μl sepharose was added was added to the sample. After 3 h incubation on a rotating 
wheel at 4°C the sepharose was washed twice with RIPA buffer, twice with TAP lysis buffer (50 mM 
HEPES-KOH [pH 8.0], 100 mM KCl, 10% glycerol, 2 mM EDTA, 0,1% IGEPAL CA-630) and 3 times 
with 50 mM ammonium bicarbonate. 90% of each sample was stored at -80°C and further processed 
for mass spectrometry. An aliquot (10% of the sample) was used for Western Blot analysis for quality 
control. Therefore, we incubated the sample at 90°C for 5 min in 95% formamide containing 10 mM 
EDTA and 1 mM biotin and subsequently Laemmli buffer was added.  
Mass spectrometry 
The beads were resuspended in 200 μl of 50 mM ammonium bicarbonate containing 2 μl trypsin 
(Promega, V511A). Samples were incubated for 16 h in a Thermomixer at 37°C and 750 rpm shaking. 
Afterwards, 1 μg of trypsin was added and the samples were incubated further for 2 h. Next, samples 
were centrifuged at 400 g for 2 min and the supernatant transferred to a new vial. To ensure complete 
bead removal, the samples were centrifuged at 16000 g for 10 min. The supernatant was transferred 
to a new vial containing 5 μl of trifluoroacetic acid. Each sample was loaded on two StageTips 
(Rappsilber et al., 2003) for desalting. Eluates of each sample were pooled together prior to MS 
analysis. 
For all the samples, 5 μl were injected in duplicates on a LC-MS/MS system (EkspertNanoLC 415 
[Eksigent] coupled to Q Exactive HF [Thermo]), using a 240 min gradient ranging from 2% to 45% of 
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solvent B (80% acetonitrile, 0,1% formic acid; solvent A= 5% acetonitrile, 0,1% formic acid). For the 
chromatographic separation a 30 cm long capillary (75 um inner diameter) was packed with 1.8 
micron C18 beads (Reprosil-AQ, Dr. Maisch). On one end of the capillary nanospray tip was generated 
using a laser puller (P-2000 Laser Based Micropipette Puller, Sutter Instruments), which allowed 
fretless packing. The nanospray source was operated with a spay voltage of 2.3 kV and an ion transfer 
tube temperature of 260°C. Data were acquired in data dependent mode using the top10 method 
(one survey MS scan with resolution 60000 at m/z 200, followed by up to 10 MS/MS scans on the 
most intense ions, resolution 15000, intensity threshold 5000). Once selected for fragmentation, the 
ions were excluded from further selection for 30 sec to increase new sequencing events. 
The raw data were analyzed using the MaxQuant proteomics pipeline ( v1.5.3.30 and v1.5.8.3) and 
the built in the Andromeda search engine (Cox et al., 2011) with the Uniprot Human database. 
Carbamidomethylation of cysteines was chosen as fixed modification, oxidation of methionine and 
acetylation of N-terminus were chosen as variable modifications. The search engine peptide 
assignments were filtered at 1% FDR and the feature match between runs was not enabled. Other 
parameters were left as default.  
Mass spectrometry proteomics data have been uploaded to ProteomeXchangeConsortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE (Perez-Riverol et al., 2019) partner 
repository with the dataset identifier PXD018313. 
Data analysis 
First, we excluded those protein groups that were identified by MaxQuant as potential contaminants 
and by reverse peptide sequences. We requested that the number of razor unique peptides per 
protein group was at least 3. The fold change enrichment in HDLBP BioID was calculated by dividing 
the LFQ values from the doxycycline (Dox)-treated condition with untreated condition-derived LFQ 
values. We obtained 3 biological replicates (batches 1, 2 and 3) of the Dox-treated cells and only 2 
biological replicates of the untreated controls (batches 2 and 3). Therefore, we divided the Dox batch 
1 with untreated batch 2 to finally obtain enrichment values for 3 replicates. In order to be defined 
as enriched in the HDLBP BioID, we requested that the protein enrichment value was at least 3 and 
that the log2-transformed LFQ intensity in the Dox-treated condition was at least 27. For proteins 
where the calculation of enrichment values was not possible due to the fact that LFQ intensity in the 
untreated condition equaled zero, we requested that the log2-transformed LFQ intensity in the Dox-
treated condition was at least 27. These filtering criteria were applied separately for each biological 
replicate and therefore the protein group had to fulfill them in all 3 replicates to be defined as 
enriched. Next, we ranked the enriched proteins by averaging their LFQ intensity in the Dox condition 
over 3 replicates. To visualize the top 60 enriched protein groups by mean LFQ, we additionally 
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displayed the mean log2-transformed enrichment values. For those proteins that did not have an 
enrichment value due to the fact that LFQ intensity in the untreated condition equaled zero, we used 
a maximum of the mean enrichment value and added a value of 2. 
 
Related to results chapter [7] 
Electron microscopy 
HEK293 WT and HDLBP knockout cell lines (1 (15 cm) dish per replicate) were grown to 70% 
confluency. Cells were fixed with fixation buffer (2% formaldehyde, 1% glutaraldehyde in 0,1 M 
phosphate buffer) for 24 h. After treating the cells with 1% osmium tetroxide for 3 h they were 
dehydrated through a graded series of ethanols and embedded in Poly/Bed 812 (Polysciences). 
Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a Morgagni 
electron microscope (Thermo Fisher Scientific). Digital images were taken with a Morada CCD 
camera and the iTEM software (EMSIS).   
 
Related to results chapter [8-9] 
Ribosome profiling and data analysis  
Experimental conditions 
Ribosome profiling was carried out as described previously (Ingolia et al., 2009) with minor 
modifications. HEK293 WT and HDLBP knockout cell lines (1 10 cm dish per replicate) were grown 
to ~90% confluency. The cells were washed with ice cold PBS containing 100 μg/ml cycloheximide. 
The PBS was thoroughly removed. Plates were put on liquid nitrogen for 10 sec and subsequently on 
ice. 400 μl mammalian polysome buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM MgCl2, 1 mM 
DTT, 100 μg/ml cycloheximide, 1% Triton X-100 and 25 U/mL TurboDNase [Thermo Fisher 
Scientific]) per plate was added. The cells were scraped, collected and the lysates were passed 10 
times through a 26 G needle. After clearing the cell lysates by centrifugation (20000 g, 10 min, 4°C) 
120 μl cell lysate aliquots were snap frozen and subsequently stored at -80°C. One aliquot of cell 
lysate was used for RNA-sequencing (see “RNA-sequencing library preparation”). Therefore, the RNA 
was isolated using Trizol LS (Thermo Fisher Scientific) in combination with RNA Clean & 
Concentrator-25 kit (Zymo Research). Another aliquot of cell lysate was used to isolate the ribosome-
protected fragments by adding 300 U RNase I (Thermo Fisher Scientific) for 45 min at slow agitation 
at room temperature. Meanwhile, MicroSpin S-400 HR Columns (GE Healthcare) were equilibrated 
by adding regularly ice cold mammalian polysome buffer (without DTT, cycloheximide, Triton X-100, 
TurboDNase) to the columns. Next, the columns were centrifuged (600 g, 4 min, 4°C). 100 U 
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SUPERaseIn (Thermo Fisher Scientific) per sample was added, mixed and the cell lysates were 
applied dropwise to the columns (100 μl cell lysate per column). The columns were centrifuged (600 
g, 2 min, 4°C). The flow-through was collected and the RNA was isolated using Trizol LS (Thermo 
Fisher Scientific) in combination with RNA Clean & Concentrator-25 kit (Zymo Research). Next, the 
ribosome-protected fragments were depleted with the RiboZero Kit (Illumina) according to 
manufacturer´s protocol using 5 μg RNA as input. The remaining RNA was separated on a 17% 
denaturing urea-PAGE gel (Carl Roth). RNA fragments in the range from 27 nt to 30 nt were excised 
(defined by markers (see “Oligonucleotides”)). Sequencing libraries were generated as described in 
the PAR-CLIP section and next generation sequencing was performed on a HiSeq 2500 Illumina 
instrument (1x51+7 cycle). 
Data analysis 
Reads were demultiplexed and adapter sequences were removed by Flexbar (2.5). Next, the reads 
were collapsed to remove PCR duplicates, followed by removal of random nucleotides (four on both 
5’ and 3’ end of the reads) using fastx_trimmer (FASTX Toolkit 0.0.14). Reads aligning to rRNA 
sequences and other sources of contamination using a custom index were removed by Bowtie2 
(v2.3.2). The remaining sequences were aligned to the human transcriptome (hg19) using STAR 
aligner (2.5.3a) using GTF annotation file Gencode v19 by retaining only the reads that uniquely 
mapped to the hg19 genome (parameters --outFilterMultimapNmax 1 --outFilterMismatchNmax 5 --
outFilterMatchNmin 15 --alignSJoverhangMin 5 --seedSearchStartLmax 20 --outSJfilterOverhangMin 
30 8 8 8 --quantMode TranscriptomeSAM). Transcriptome BAM files were converted to the bed 
format using BedTools bamToBed (v2.26.0) and bed files were then input into riboWaltz (v1.1.0) 
(Lauria et al., 2018), which we used for downstream quality control and P site coverage analysis.  
Quality control of ribosome profiling data was carried out using riboWaltz, which outputs 
metaheatmaps of read coverage around start and stop codons for all possible read lengths. 
Additionally, we used riboWaltz to calculate optimal P site offset (13 nt) and to obtain P site coverage 
per nucleotide. To include a P site in the downstream metagene analysis we requested a minimal P 
site nucleotide coverage of 5 in at least one of the samples.  
To perform the metagene analysis of P site occupancy around the start and stop codons, we excluded 
the P site coverage corresponding to the first 2 and the last 2 codons of the CDS. The reason for this 
is the high read coverage at these positions due to ribosome initiation and termination. Including 
these would prevent meaningful normalization and mask the differences in the regions around start 
and stop codons. P site coverage per nucleotide was normalized for library size and summed for each 
codon. The codon coverage was scaled to the mean CDS coverage excluding the coverage at the 
extremities and we included all CDS that had total codon coverage of 5 or higher. For all interrogated 
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codon positions within the CDS, the scaled P site coverage was averaged and a rolling mean over 10 
nt was used to smooth the signal in the final metagene plot. 
In order to perform the metagene analysis of codon occupancy around targeting signals 
(Figs.5C,S5D), we summed the P site coverage per codon. The obtained codon coverage was 
normalized to the mean coverage within codons 20-40 in each CDS, as described previously 
(Chartron et al., 2016). For all interrogated codon positions within the CDS (1-500), the scaled P site 
coverage was next averaged over all well-quantified transcripts (mRNAs with TPM>=10) and a 
rolling mean over 5 nt was used to smooth the signal in the final metagene plot. 
To calculate translation efficiencies per gene, we used RSEM (v1.2.2) which supplied us with read 
counts and TPM values per gene. The differences in translational efficiency, as well as in mRNA 
abundance and due to both effects (transcription and translation) were detected by DESeq2 (1.18.1) 
with an interaction term model as described previously (Chothani et al., 2019). Briefly, RPF read 
counts were normalized using the DESeq2 estimateSizeFactors function by taking into account all 
read counts and DESeq2 was run with default parameters. The log2-transformed fold changes for 
downstream comparisons were taken directly from the DESeq2 output.  
For codon level analysis, we made use the codon frequency analysis available within riboWaltz. 
Differences in codon frequency were calculated by subtracting the codon occupancy values between 
conditions and additionally standard deviations between replicates were calculated. 
 
Pulsed SILAC and data analysis 
Experimental conditions 
HEK293 WT and HDLBP knockout cell lines were cultured for at least 3 passages in arginine- and 
lysine-free DMEM (Life Technologies) containing 10% dialyzed FBS (Pan-Biotech), 1% glutamax 
(Life Technologies), 1% sodium pyruvate (Life Technologies) and “light” form amino acids  0,2 mM 
L-arginine (Sigma-Aldrich) and 0,8 mM L-lysine (Sigma-Aldrich). Next, cells were seeded in 6-well 
plates (450000 cells per well) and after 48 h the “light” form medium was removed. Subsequently, it 
was replaced by either medium containing the “medium” form amino acids (L-[13C6]-arginine 
(Sigma-Aldrich), L-[2H4]-lysine (Cambridge Isotope Laboratories)) or “heavy” form amino acids (L-
[13C6,15N4]-arginine (Sigma-Aldrich), L-[13C6,15N2]-lysine (Cambridge Isotope Laboratories)). 
After 2 h or 4 h cells were fractionated. Cell fractionation was performed as described above with 
reduced volumes: 6-wells were washed with cold PBS and 544μl PBS containing 50 μg/ml 
cycloheximide was added for 10 min. In the meantime, cells were scraped and one 6-well HEK293 
and one 6-well HEK293 HDLBP knockout cells were combined. Downstream we used 100 μl of 
permeabilization buffer, 544 μl of wash buffer and 100 μl of lysis buffer. After clarification of the 
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fractions, we recovered 90 μl sample, added 810 μl pure EtOH and samples were submitted to mass 
spectrometry.  
Mass spectrometry 
Samples were resuspended in 6 M urea, 2 M Thiourea, 10 mM HEPES pH 8 solution and the proteins 
were reduced with 10 mM DTT and alkylated with 55 mM iodoacetamide at room temperature. For 
lysis, we incubated the proteins with 1% (w/w) lysyl endopeptidase (Wako) at room temperature 
for 3 h, diluted with 50 mM ammonium bicarbonate solution for final urea concentration of 2 M and 
incubated with 1% (w/w) trypsin (Promega) under constant agitation at room temperature for 16 h. 
Next, peptides were acidified with 1% (v/v) trifluoroacetic acid, and desalted with C18 Stage Tips 
(Rappsilber et al., 2003). Prior to LC-MS/MS analysis, the peptides were eluted with 50% acetonitrile 
0,1% formic acid, dried and resuspended in 3% acetonitrile, 0,1% formic acid (Buffer A). Peptide 
concentration was determined based on 280 nm UV light absorbance. 
Reversed-phase liquid chromatography was carried out employing an EASY nLC II (Thermo Fisher 
Scientific) using self-made C18 microcolumns (75 μm ID, packed with ReproSil-Pur C18-AQ 1.9-μm 
resin, Dr. Maisch, Germany) connected on-line to the electrospray ion source (Proxeon, Denmark) of 
both an Orbitrao HF-X or an OrbitrapExploris 480 mass spectrometer with the FAIMS module 
installed and in application mode “Peptide” (Thermo Fisher Scientific). The peptides were eluted at 
a flow rate of 250 nL/min over 2 or 4 h with a stepwise increasing gradient of 4,74% to 81,3% 
acetonitrile in constant 0,1% formic acid. As settings for data dependent analysis on Orbitrap HF-X 
we used: positive polarity, full scan (resolution, 60000; m/z, 350-1800, AGC target, 3e6; injection 
time, 10 ms) followed by top20 MS/MS scans with higher-energy collisional dissociation (resolution, 
15000; m/z, 200-2000; AGC target, 1e5. injection time, 22 ms; isolation width, 1.3 m/z; normalized 
collision energy, 26). The settings for data dependent analysis on Exploris were: positive polarity, 1 
second cycle time, full scan (resolution, 60000; m/z, 350-1800, AGC target, 300%; injection time, 30 
ms; FAIMS CV, -40, -55 or -70 mV) followed by MS/MS scans with higher-energy collisional 
dissociation (resolution, 7500; m/z, 200-2000; AGC target, 100%. injection time, 25 ms; isolation 
width, 1.3 m/z; normalized collision energy, 28). Ions with an unassigned charge state, singly charged 
ions, and ions with charge state higher than 5 were rejected and former target ions selected for 
MS/MS were dynamically excluded. 
The samples were measured in technical duplicates. Raw files were analyzed using the MaxQuant 
software (v1.6.0.1) (Cox and Mann, 2008) with default parameters and files measured by Q-exactive 
HF-X or Exploris machines were grouped in same experimental group, while technical and biological 
replicates were kept separated. Search parameters included two missed cleavage sites, cysteine 
carbamidomethyl as fixed modification, and methionine oxidation, protein N-terminal acetylation 
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and asparagine or glutamine deamidation (only identification) as variable modifications. Triple 
multiplicity was used to search for light (Lys0, Arg0), medium-heavy (Lys4, Arg6) and heavy (Lys8, 
Arg10) peptides. The peptide mass tolerance was 20 and 4.5 ppm for first and main search, 
respectively. Database search was carried out with Andromeda embed in MaxQuant (Cox et al., 2011) 
against UniProt/Swiss-Prot human database (downloaded on January 2019) with common 
contaminant sequences provided by MaxQuant. FDR was set to 1% at peptide spectrum match (PSM) 
and protein levels. Minimum peptide count required for protein quantification was set to 2. Match 
between runs was turned on, search was performed with Requantify turned on, and again with 
option turned off.  
Mass spectrometry proteomics data have been uploaded to ProteomeXchangeConsortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository with the dataset 
identifier PXD018316. 
Data analysis  
For analysis, we excluded potential contaminants, reverse database hits and peptides only identified 
by modification. Next, unscrupulous ratios, defined as a SILAC pair quantified from both requantified 
intensities, were removed from further analysis. These were rare and only found in a small fraction 
of requantified SILAC ratios. The MaxQuant normalized SILAC ratios were used for analysis. For 
average calculations, we only accepted proteins with one or more values in at least one replicate from 
both forward and reverse SILAC label experiments. For the forward experiment, the heavy SILAC 
label corresponded to the HEK293 HDLBP KO cells, while the medium SILAC label corresponded to 
WT cells. For the reverse experiment we switched the labels. We noticed that the samples from the 
membrane fractions after 4 h of gradient fractionation contained higher iBAQ values for SP and TM 
containing proteins. Therefore, we only used membrane fraction results after 4 h for further analysis 
and excluded the 2 h data set. Protein names from the MaxQuant output were mapped to the RNA-
sequencing fractionation data table to obtain the same classification as in other analyses. 
Distributions of H/M SILAC ratios between different classes of proteins were compared by 
cumulative density function. Significance was evaluated by the Wilcoxon rank-sum test.  
 
Polysome profiling 
Polysome profiling was performed as described previously (Jagannathan et al., 2011). Stable cell lines 
expressing FLAG/HA-HDLBP (4 dishes (15 cm) per replicate) were grown to 90% confluency. 4 ml 
ice cold PBS containing 100 μg/ml cycloheximide per plate was added and cells were scraped using 
a plastic scraper. After pelleting the cells (1200 rpm, 4 min, 4°C), cells were resuspended with 250 μl 
polysome lysis buffer (20 mM Tris-HCl [pH 7.4], 150 mM KCl, 5 mM MgCl2, 0,5 mM DTT, 0,5% IGEPAL 
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CA-630, EDTA-free protease inhibitor cocktail [Roche], 100 μg/ml cycloheximide). The lysate was 
passed for 4 min through a 26 G needle and centrifuged (17000 g, 10 min, 4°C). The supernatant was 
layered onto a 10 ml linear sucrose gradient (15-45%) using a Sorvall WX 90 ultracentrifuge (Thermo 
Fisher Scientific) at 36000 rpm at 4°C for 2 h 30 min. The sucrose gradients were prepared by first 
adding 5 ml of 15% sucrose solution (15% sucrose in polysome lysis buffer (without DTT, EDTA-free 
protease inhibitor, cycloheximide) in a centrifuge tube (Seton, 7030) and careful under laying of 45% 
sucrose solution. The gradient station (Biocomp) was used to prepare the gradients and to collect 20 
fractions per gradient. Proteins from each fraction were extracted by standard TCA precipitation and 
analyzed by Western Blot.  
 
Related to results chapter [9] 
ncRNA-sequencing and data analysis 
Experimental conditions 
For normalization of tRNA abundance in the HDLBP PAR-CLIP dataset we used the RNA-sequencing 
library preparation protocol based on small RNA cloning approaches (Hafner et al., 2008; König et 
al., 2010; Milek et al., 2017; Van Nostrand et al., 2016). Total RNA was extracted from HEK293 cells 
with Qiagen RNAeasy kit according to the manufacturer’s protocol and 2 μg were fragmented in a 
total volume of 100 μl fragmentation solution (10 mM ZnOAc, 100 mM Tris buffer [pH 8.0]) in a thin-
walled PCR tube at 95°C for 55 s.  Next, the samples were immediately cooled on ice. The RNA was 
purified with RNA Clean and Concentrator kit (Zymo Research) according to the manufacturer’s 
protocol. RNA was treated with 10 U of calf intestine alkaline phosphatase in 1x CutSmart buffer 
(both from New England Biolabs) for 1 h at 37 °C. The samples were immediately cooled on ice and 
RNA was purified with RNA Clean and Concentrator kit (Zymo Research) according to the 
manufacturer’s protocol. RNA was then treated with 20 U of T4 polynucleotide kinase in 1x T4 PNK 
reaction buffer (both from New England Biolabs) supplemented with 0,1% (v/v) Triton-X100 for 30 
min at 37°C. The samples were immediately cooled on ice and RNA was purified with RNA Clean and 
Concentrator kit (Zymo Research) according to the manufacturer’s protocol. Next, the 3’ adaptor was 
ligated, which was performed for 16 h at 16 °C in a total volume of 20 μl in the presence of 2 U of T4 
RNA ligase 2 truncated K227Q, 1x RNA ligase buffer, 25% PEG-8000 (all from New England Biolabs) 
and 25 pmol of pre-adenylated 4N-RA3 adapter (see “Oligonucleotides”). Afterwards, RNA was 
separated on 10% Novex TBE Urea gels. Fragments in the range of 65-100 nt were excised and eluted 
in 300 mM NaCl overnight at 4 °C with 900 rpm agitation. RNA was then precipitated by the addition 
of 0,5 μl GlycoBlue co-precipitant, 3 volumes of absolute ethanol and incubation for at least 2 h at -
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80 °C. The precipitated RNA was reverse transcribed for 30 min at 37 °C in a total volume of 20 μl 
containing 1x buffer (25 mM Tris [pH 8.6], 30 mM NaCl and 5 mM dithiotreitol), 4.5 pmol RTP primer 
(see “Oligonucleotides”), 4 mM each dNTP, 20 mM MgCl2, 7.1% (v/v) dimethylsulfoxide and 10 U of 
AMV reverse transcriptase (Promega). Subsequently, RNA was removed by RNase H (5 U) treatment 
for 30 min at 37 °C (New England Biolabs) and ssDNA was separated on 10% Novex TBE Urea gels. 
Fragments ranging from 65-100 nt were excised and eluted in 300 mM NaCl overnight at 4 °C with 
900 rpm agitation. Single stranded DNA (ssDNA) was then precipitated by the addition of 0,5 μl 
GlycoBlue co-precipitant, 3 volumes of absolute ethanol and incubation for at least 2 h at -80 °C. Next, 
the 5’adaptor was ligated, which was performed for 16 h at 22 °C in a total volume of 20 μl. The 
reaction contained precipitated ssDNA, 60 U T4 RNA ligase 1, 1x RNA ligase buffer, 22.5% PEG-8000, 
1 mM ATP (all from New England Biolabs) and 50 pmol of 4N-SRC-cDNA adapter (see 
“Oligonucleotides”). The ssDNA was purified with DNA Clean and Concentrator kit (Zymo Research) 
according to the manufacturer’s ssDNA protocol. PCR amplification for the final library was 
performed according to the Truseq small RNA protocol (Illumina). Typically, 14 cycles of 
amplification were necessary to obtain a sufficient amount of the final cDNA library in the size range 
of 150-220 bp (average size 180 bp). PCR reactions were separated on a 2.5% agarose gel. The final 
DNA library of the expected size range was excised and sequenced on a HiSeq 4000 Illumina 
instrument (1x51+7 cycle). 
Data analysis  
Reads were demultiplexed and adapter sequences were removed by Flexbar (2.5). Reads were 
collapsed to remove PCR duplicates, followed by removal of random nucleotides (four on both 5’ and 
3’ end of the reads) by fastx_trimmer (FASTX Toolkit 0.0.14). To obtain accurate mapping results to 
transcripts originating from repetitive genomic loci, we made use of the same strategy as for PAR-
CLIP analysis (see “PAR-CLIP and data analysis”). 
 
Mapping to reference tRNAs and quantification 
Initially, we downloaded mature tRNA fasta files from GtRNADb (http://gtrnadb.ucsc.edu/, hg19 
build) and kept only one fasta sequence per tRNA molecule to avoid mapping non-uniquely due to 
tRNA gene duplications and pseudogenes. The tRNAs missing from this initial set were obtained from 
HEK293 Hydro-seq results (Gogakos et al., 2017). As a result our custom made FASTA tRNA reference 
contained 58 unique tRNAs. Reads were mapped to this reference using Bowtie 2 (v.2.3.2) and 
custom scripts using BedTools (v2.26.0) intersect and getfasta commands were used to obtain T-to-
C conversion counts per position and per tRNA. By inspection of the aligned reads in IGV and using 
the Modomics database (https://iimcb.genesilico.pl/modomics) (Boccaletto et al., 2018), we realized 
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that T-to-C conversions were detected at dihydrouridine bases, which were present also in libraries 
prepared from total HEK293 RNA with no 4sU and UV treatment. Therefore, we removed these 
positions from T-to-C conversion counting by using a custom made bed file of all dihydrouridine 
bases. To quantify the tRNA abundance in HEK293 cells we used our ncRNA-seq dataset from 
randomly fragmented total HEK293 RNA (see “ncRNA-sequencing and data analysis”). To calculate 
the enrichment of tRNAs in HDLBP PAR-CLIP, we first normalized T-to-C conversion counts and read 
counts per tRNA for library size. Next, for each tRNA, T-to-C conversion counts were divided by the 
respective read count per tRNA from the ncRNA-seq samples to obtain the enrichment score. 
Transition specificity per T-to-C conversion within one tRNA was obtained by dividing the T-to-C 
conversion count with total read coverage at the same nucleotide position. Codon usage information 
was downloaded from https://www.kazusa.or.jp/codon/. The dihydrouridine positions along with 
the entire tRNA processing pipeline and tRNA sequences are available from GitHub 
https://github.com/mmilek/hdlbp/trna/. 
 
Related to results chapter [10] 
Gaussia luciferase and SEAP assays 
HEK293 WT and HDLBP knockout cell lines were seeded in 6-well plates (500000 cells per well). 
After 24 h cells were transfected using Fugene6 reagent (Promega) with plasmids expressing Gaussia 
luciferase (Gluc) or secreted alkaline phosphatase (SEAP) and Firefly luciferase (Fluc) according to 
manufacturer´s protocol (see “Plasmids” for details). 48 h after transfection cells were split (70000 
cells per well) into white bottom 96-well plates (Thermo Fisher Scientific, 136101). 24 h later a 
proportion of medium was transferred to a new white bottom 96-well plate. The Gluc signal was 
measured using the Gaussia Luciferase Flash Assay Kit (Thermo Fisher Scientific, PI16159) and the 
SEAP signal was quantified by the NovaBrightPhospha-Light EXP Assay Kit (Thermo Fisher Scientific, 
N10577) according to manufacturer´s protocol. The Fluc activity was determined in the remaining 
medium and cells with the Firefly Luc One-Step Glow Assay Kit (Thermo Fisher Scientific, PI16197). 
Gluc and SEAP signal was normalized to the Fluc signal. Each experiment was carried out using 5 
technical replicates and the Gluc assay was performed 5 times and the SEAP assay 4 times.  
For SEAP rescue experiments we transfected HEK293 WT and HDLBP KO gRNA2 cells with SEAP, 
Fluc and additionally with pFRT/TO/FLAG/HA-HDLBP for 24 h. Subsequent steps of the experiment 
were carried out as described above.  
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Flow cytometry 
To quantify changes in CD71 surface expression, 3x105 HEK293 WT and HDLBP KO cells were stained 
with an anti-CD71 antibody or an isotype control diluted in 1% BSA/PBS for 15 min at 4°C. After 
washing the cells with PBS, cells were analyzed by flow cytometry using an Aria III (BD) machine. To 
exclude dead cells, cells were stained with propidium iodid (Miltenyi Biotec). The FlowJo analysis 
software was used to determine mean fluorescence intensities of CD71. The experiment was carried 
out 4 times.  
 
Related to results chapter [11] 
Cell Proliferation and Migration Assays 
For the determination of cell proliferation, 103 A549 WT or HDLBP KO cells were seeded in 96-well 
plates. Cell confluency was monitored for 5 days using an IncuCyte S3 system (Sartorius) with 4x 
magnification to allow a whole well scan. Confluence masks were obtained by the IncuCyte analysis 
software. Cell viability and DNA content were quantified using CellTiter Glo (Promega) supplemented 
with 1/2000 SYBR Green I (Thermo Fisher) according to manufacturer’s protocols. Luminescence 
and fluorescence intensities were determined in a GloMax microplate reader (Promega). For the 
scratch wound migration analysis, 2.5x104 A549 WT and HDLBP KO cells were seeded in a 96-well 
ImageLock plate (Sartorius) for 24 h. The wound areas were created on confluent cell monolayers by 
a 96-well WoundMaker (Sartorius). Wound healing was monitored in 1 h intervals using an IncuCyte 
S3 system at 10x magnification. Confluence and wound masks were obtained and quantified by the 
IncuCyte analysis software. 
 
Xenograft Assay 
Athymic nude mice (immunodeficient, FOXN1nu/nu) were purchased from Charles River. Animals 
were treated according to the local guidelines of the Martin-Luther-University Halle-Wittenberg. 
Subcutaneous xenograft assays were carried out as previously described (Muller et al., 2018). Briefly, 
A549 WT and HDLBP KO cells were transduced at 10 MOI (multiplicity of injection) with iRFP-
encoding lentiviruses. 1x106 cells were harvested in media supplemented with 50% (v/v) matrigel 
(Sigma Aldrich) for the subcutaneous injection into nude mice. WT and HDLBP KO cells were injected 
into the left and the right flanks of six-week old nude mice. Mice were held with access to chlorophyll-
free food (Altromin C1086) ad libitum in order to reduce background noise in weekly iRFP imaging 
using a Pearl Trilogy Imaging System (LI-COR). To determine the fluorescence intensity, we used the 
Image Studio software (LI-COR). Tumor volumes were measured and calculated using the formula 
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0.52 x L1 x L2 x L3. Once the first tumor reached the termination criteria of a 1.5 cm diameter, the mice 
were sacrificed. Palpable tumors were excised and the weight was measured. Subsequently, the RNA 
was isolated and sequencing libraries were prepared using the Next Ultra Directional RNA Library 
Prep Kit (NEB). Next generation sequencing performed on a HiSeq 4000 Illumina instrument 




Data and code availability 
PAR-CLIP, RNA-seq and ribosome profiling data from this study have been uploaded to the NCBI Gene 
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession GSE148262. BioID 
and pSILAC raw data have been submitted to the ProteomeXchange 
(http://www.proteomexchange.org) under the identifiers PXD018313 and PXD018316 respectively. 




Antibody Vendor  Dilution 
APC-isotype control Miltenyi Biotec RRID:AB_2733447 1 : 50 
BCAP-31 Proteintech, 11200-1-AP 1 : 2000 
CD71-APC Miltenyi Biotec RRID:AB_2660542 1 : 50 
Goat Anti-Mouse Immunoglobulins/HRP Agilent-Dako, P0447 1 : 4000 
Goat Anti-Rabbit Alexa Fluor 488  Invitrogen, A-11008 1 : 2000 
Goat Anti-Rabbit Immunoglobulins/HRP Agilent-Dako, P0448 1 : 4000 
HA Covance, MMS-101P-1000 1 : 5000 
HDLBP Abcam, ab109324 1 : 10 000 
RPL7 Abcam, ab72550 1 : 5000 
RPS6 Cell Signaling, #2217 1 : 1000 








27 nt marker 5′-AUGUACACGGAGUCGAGCUCAACCCGC-P 
30 nt marker 5′-AUGUACACGGAGUCGAGCUCAACCCGCAAC-P 
3’ adaptor 4N-RA3 5’-rApp/NNNNTGGAATTCTCGGGTGCCAAGG/3InvdT/ 
5’ adaptor OR5-4N 5’-GUUCAGAGUUCUACAGUCCGACGAUCNNNN 
5’adaptor 4N-SRC-cDNA /5Phos/NNNNGATCGTCGGACTGTAGAACTCTGAAC-SpC3 
RT primer RTP 5’ GCCTTGGCACCCGAGAATTCCA 









































Vector pDONR221 carrying the HDLBP CDS (obtained from the hORFeome V5.1 collection) was 
recombined into pFRT/TO/FLAG/HA-DEST (Addgene ID: 26360) and pDEST5-BirA-FLAG-N-term-
pcDNA5-FRT-TO (Couzens et al., 2013) using the Gateway LR Clonase II (Thermo Fischer Scientific) 
according to the manufacturer´s protocol. For the SEAP secretion assays we made use of pEZX-GA01 
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(GeneCopoeia) and additionally pFRTpsiCHECK containing Renilla luciferase and Firefly luciferase. 
For the SEAP rescue secretion assays we replaced Renilla luciferase in pFRTpsiCHECK by SEAP 
luciferase. Therefore, we amplified SEAP from pEZX-GA01 with the primers SEAP_fwd and SEAP_rev 
(see “Oligonucleotides”) and ligation into NheI and NotI restriction sites. For the Gaussia luciferase 
secretion assay, we replaced Renilla luciferase in pFRTpsiCHECK by Gaussia luciferase. Therefore, we 
amplified Gaussia from pEZX-GA01 with the primers Gaussia_fwd and Gaussia_rev (see 
“Oligonucleotides”) and ligation into NheI and NotI restriction sites. All vectors have been submitted 
to Addgene.   
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3’UTR | three prime untranslated region 
4sU | 4-thiouridine 
5’UTR | five prime untranslated region 
BirA | Biotin ligase  
bp | base pairs  
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cDNA | complementary DNA 
CDS | coding sequence 
CRISPR | clustered regularly interspaced short 
palindromic repeats 
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DNA | deoxyribonucleic acid 
EDTA | ethylenediaminetetraacetic acid  
ER | endoplasmic reticulum 
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gRNA 1/2 | guide RNA 1/2 
Gluc | Gaussia luciferase 
GO | gene ontology 
HDLBP | high-density lipoprotein binding 
protein  
HEK | human embryonic kidney 
HRP | horseradish peroxidase 
iBAQ | intensity-based absolute 
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irCLIP | infrared crosslinking and 
immunoprecipitation 
KH | hnRNP K homology  
KO | knockout 
MFI | mean fluorescent intensity 
mRNA | messenger RNA 
nt | nucleotide  
N-terminus | amino-terminus 
PAR-CLIP | photoactivatable 
ribonucleoside-enhanced crosslinking and 
immunoprecipitation  
PBS | phosphate buffered saline 
PCR | polymerase chain reaction  
PIC | pre-initiation complex 
pSILAC | pulsed stable isotype labelling with 
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RBP | RNA-binding protein 
RIP | RNA immunoprecipitation 
RNA | ribonucleic acid  
rpm | revolutions per minute 
RREs | RNA recognition elements 
rRNA | ribosomal RNA 
S | sedimentation coefficient 
SDS | sodium dodecyl sulfate  
SDS-PAGE | sodium dodecyl sulfate 
polyacrylamide gel electrophoresis  
SEAP | secreted alkaline phosphatase 
SECReTE | secretion enhancing cis-
regulatory targeting element 
SignalP/SP | signal peptide 
SRP | signal recognition particle 
TBST | tris buffered saline with Tween  
TCA | trichloroacetic acid 
TM | transmembrane domain 
TPM | transcripts per million  
tRNA | transfer RNA 
TS | targeting signal  
U | uracil 
UV | ultraviolet 
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